Muscarinic receptor subtypes and smooth muscle function

Pharmacological Reviews

Volumn 48, Issue 4, 1996, Pages 531-565

  Eglen, Richard M ^a   Hegde, Sharath S ^a   Watson, Nikki ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ADENYLATE CYCLASE; ATROPINE; CYCLIC AMP; DARIFENACIN; HIMBACINE; ION CHANNEL; IPRATROPIUM BROMIDE; MEBEVERINE; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OTENZEPAD; OTILONIUM BROMIDE; OXYBUTYNIN; PARA FLUOROHEXAHYDROSILADIFENIDOL; PHOSPHATIDYLINOSITIDE; PIRENZEPINE; PROPANTHELINE BROMIDE; RECEPTOR SUBTYPE; TELENZEPINE; TIOTROPIUM BROMIDE; TRIPITRAMINE; UNCLASSIFIED DRUG; VAMICAMIDE; ZAMIFENACIN;

BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DUODENUM ULCER; EXTRAOCULAR MUSCLE; GASTROINTESTINAL TRACT; HUMAN; IRRITABLE COLON; NONHUMAN; PEPTIC ULCER; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; TACHYCARDIA; URGE INCONTINENCE; UROGENITAL SYSTEM; VASCULAR SMOOTH MUSCLE; VISUAL IMPAIRMENT; XEROSTOMIA;

ANIMALS; HUMANS; MUSCLE, SMOOTH; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 0030442725     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (484)

1. AARONSON, P. I. AND SMINOV, S. V.: Membrane ion channels in vascular smooth muscle excitation-contraction coupling. In Pharmacology of Vascular Smooth Muscle, ed. by C. J. Garland and J. A. Angus, pp. 136-158, Oxford University Press, England, 1996.
2. ABDEL-LATIF, A. A., YOUSUFZAI, S. Y. K., DE, S., AND TACHADO, S. D.: Carbachol stimulates adenylyl cyclase and phospholipase C and muscle contraction-relaxation in a reciprocal manner in dog iris sphincter muscle smooth muscle. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 226: 351-361, 1992.
3. ABRAMSON, F. B., BARLOW, R. B., MUSTAFA, M. G., AND STEPHENSON, R. P.: Relationship between chemical structure and affinity for acetylcholine receptors. Br. J. Pharmacol. 37: 207-233, 1969.
4. AKAH, P. A. AND ORIOWO, M. A.: Muscarinic receptor agonist-antagonist interaction in the rat rectum: are there distinct ways of activating the same receptors? J. Pharm. Pharmacol. 37: 589-592, 1985.
5. 2 muscarinic receptor subtype associated with inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris. J. Pharmacol. Exp. Ther. 243: 624-632, 1987.
6. 3H]-acetylcholine secretion in the guinea-pig urinary bladder in vitro. J. Pharmacol. Exp. Ther. 274: 458-468, 1995.
7. AL-ZUHAIR, A., GOSLING, J. A., AND DIXON, J. S.: Observations on the structure and autonomic innervation of the guinea-pig seminal vesicle and ductus deferens. J. Anat 120: 81-93, 1975.
8. AMANN, R.: Neural regulation of ureteric motility. In Nervous Control of the Urogenital System, ed. by C. A. Maggi, pp. 209-225, 1993.
9. ANDERSON, K. E.: Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev. 45: 253-308, 1993.
10. ANDERSSON, K. E., HOLMQUIST, F., FOVAEUS, M., HEDLUND, H., AND SUNDLER, R.: Muscarinic receptor stimulation of phosphoinositide hydrolysis in the human isolated urinary bladder. J. Ural. 146:1156-1159, 1991.
11. ANGELI, P., BRASILI, L., GIANNELLA, M., GUALTIERI, F., PICCHIO, M. T., AND TEODORI, E.: Chiral muscarinic agonists possessing a 1,3-oxathiolane nucleus: enantio and tissue-selectivity on isolated preparations of guinea-pig ileum and atria and of rat urinary bladder. Naunyn Schmiedebergs Arch. Pharmacol. 837: 241-245, 1988.
12. 2 receptors in vivo by the new antagonist tripitramine. Naunyn Schmiedebergs Arch. Pharmacol. 352: 304-307, 1995.
13. B values for metiamide and atropine in the isolated stomach of the mouse. Br. J. Pharmacol. 67: 59-65, 1979.
14. BARLOW, R. B., BERRY, K J., GLENTON, P. A. M., NIKOLAOU, N. M., AND SOH, K S.: A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea-pig atrial pace-maker cells at 29°C and in ileum at 29°C and 37°C. Br. J. Pharmacol. 88: 613-620, 1976.
15. 3 muscarinic receptors by hexhydrobenzyl-fourdapine and a comparison with zamifenacin. Br. J. Pharmacol. 116: 2897-2902, 1995.
16. BARLOW, R. B., BOND, S., HOLDUP, D. W., MCQUEEN, D. S., VEALE, M. A., SMITH, T. W., STEPHENSON, G. W., AND BATSANOV, A. S.: 'FourDAPines', a new class of ileo-selective antimuscarinic drugs. Br. J. Pharmacol. 108:40P, 1992.
17. BARLOW, R. B., BURSTON, K. N., AND VIS, A.: Three types of muscarinic receptors? Br. J. Pharmacol. 68: 141-142P, 1980.
18. BARLOW, R. B., FRANKS, F. M., AND PEARSON, J. D. M.: A comparison of the affinities of antagonists for acetylcholine receptors in the ileum, bronchial muscle and iris of the guinea-pig. Br. J. Pharmacol. 46: 300-312, 1972.
19. BARLOW, R. B., MCMILLEN, L. S., AND VEALE, M. A.: The use of 4-diphenylacetoxy-N-(2-chloroethyl)-piperidine (4-DAMP mustard) for estimating the apparent affinities of some agonists acting at muscarinic receptors in guinea-pig ileum. Br. J. Pharmacol. 102: 657-662, 1991.
20. 2 muscarinic receptors. Br. J. Pharmacol. 85: 427-435, 1985.
21. BARLOW, R. B., SHEPHERD, M. K., AND VEALE, M. A.: Some differential effects of 4- diphenylacetoxy-N-(2-chloroethyl)-piperidine hydrochloride on guinea-pig atria and ileum. J. Pharm. Pharmacol. 42: 412-418, 1990.
22. BARNES, P. J.: Muscarinic receptor subtypes in airways. Life Sci. 52: 521-527, 1993.
23. BAROCELLI, E., BALLABENI, M., CHIAVARINI, M., CARAETTA, A., MOLINA, E., AND IMPICCIATORE, M.: Regional differences in motor responsiveness to antimuscarinic drugs in the rabbit isolated small and large intestine. Pharmacol. Res. 31: 43-48, 1995.
24. BAROCELLI, E., BALLABENI, V., CHIAVARINI, M., MOLINA, E., AND IMPICCIATORE, M.: Functional comparison between nuvenzepine and pirenzepine on different guinea-pig isolated smooth muscle preparations. Pharmacol. Res. 30: 161-170, 1994a.
25. 3 receptor antagonist effects of a new pirenzepine analogue in isolated guinea-pig ileal longitudinal musclemyenteric plexus. Eur. J. Pharmacol. 254: 151-157, 1994b.
26. BARON, C. B., CUNNINGHAM, M., STRAUSS, J. F., AND COBURN, R. F.: Pharmacomechanical coupling in smooth muscle may involve phosphatidylinositol metabolism. Proc. Natl. Acad. Sci. USA. 81: 6899-6903, 1984.
27. BARTLET, A. L.: An atypical action of acetylcholine on the striped muscle of the guinea-pig esophagus. Q. J. Exp. Physiol. Cogn. Med. Sci. 53: 175-180, 1968.
28. BATRA, S.: Comparison of muscarinic acetylcholine binding in the urinary bladder and submandibular gland of the rabbit. Eur. J. Pharmacol. 138: 83-88, 1987.
29. BATRA, S., BIORKLUND, A., HEDLUND, H., AND ANDERSSON, K-E.: Identification and characterization of muscarinic cholinergic receptors in the human urinary bladder and parotid gland. J. Auton. Nerv. Syst. 20: 129-135, 1987.
30. BAUDIERE, B., MONFERINI, E., GIRALDO, E., LADINSKY, H., AND BALI, J. P.: Characterization of the muscarinic receptor subtype in isolated gastric fundic cells of the rabbit. Biochem. Pharmacol. 36: 2957-2961, 1987.
31. 2 selective muscarinic receptor antagonist that penetrates into the brain. Eur. J. Pharmacol. 251: 315-317, 1994.
32. BEBBINGTON, A. AND BRIMBLECOMBE, R. W.: Muscarinic receptors in the central and peripheral nervous system. Adv. Drug Res. 2: 143-172, 1965.
33. BELLIDO, I., FERNANDEZ, J. L., GOMEZ, A., AND SANCHEZ DE LA CUESTA, F.: Oteuzepad shows two populations of binding sites in human gastric smooth muscle. Can. J. Physiol. Pharmacol. 73: 124-129, 1995.
34. BENHAM, C. D., BOLTON, T. B., AND LANG, R. J.: Membrane potential and voltage clamp recording from smooth muscle cells of rabbit jejunum (Abstract). J. Physiol. 363: 67P, 1984.
35. BERRIDGE, M. J.: The interaction of cyclic nucleotides and calcium in the control of cellular activity. Adv. Cyclic Nucleotide Res. 6: 1-98, 1975.
36. BERTRAM, J. F., GOLDIE, R. G., PAPADIMITHIOU, J. M., AND PATERSON, J. W.: Correlation between pharmacological response and structure of lung parenchymal strip. Br. J. Pharmacol. 80: 107-114, 1983.
37. BIEGER, D. AND TRIGGLE, C.: Pharmacological properties of mechanical responses of the rat oesophageal muscularis mucosae to vagal and field stimulation. Br. J. Pharmacol. 84: 93-106, 1985.
38. BLANQUET, F., ABYSIQUE, A., AND GONELLA, J.: In vivo study of the role of muscarinic receptors in the parasympathetic control of rabbit colonic motility. J. Auton. Nerv. Syst. 46: 217-227, 1994.
39. BLAYNEY, L. M., GAPPER, P. W., AND NEWBY, A.: Phospholipase C isoforme in vascular smooth muscle and their regulation by G-proteins. Br. J. Pharmacol. 118: 1003-1011, 1996.
40. 4 subtypes mediates contraction of the rabbit iris sphincter. Naunyn Schmiedebergs Arch. Pharmacol. 345: 611-618, 1992.
41. BOLGER, G. T., LUCHOWSKI, E. M., AND TRIGGLE, D. J.: Characterization of ion movements and their relationship to muscarinic receptor binding and excitation-contraction coupling in guinea-pig ileal longitudinal smooth muscle. Can. J. Physiol. Pharmacol. 67: 331-343, 1989.
42. BOLTON, T. B., LANG, R. J., AND TAKEWAKI, T.: Mechanism of action of nor-adrenaline and carbachol on smooth muscle of guinea-pig anterior mesenteric artery. J. Physiol. 361: 549-572, 1984.
43. BOLTON, T. B. AND LIM, S. P.: Action of acetylcholine on smooth muscle. Z. Kardiol. 80(suppl. 7): 73-77, 1991.
44. 3 muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of spontaneously hypertensive rat. Br. J. Pharmacol. 112: 519-524, 1994.
45. BRANDES, S. B. AND RUGGIERI, M. R.: Muscarinic receptor subtypes in normal, fetal and gravid rabbit bladder, heart and uterus. Adv. Exp. Med. Biol. 385: 241-249, 1995.
46. BRANN, M. R., ELLIS, J., JORGENSEN, H., HILL-EUBANKS, D., AND JONES, S. V.: Muscarinic acetylcholine receptor subtypes: localization and structure/function. Prog. Brain Res. 98: 121-127, 1993.
47. BRICHANT, J.-F., WARNER, D. O., GUNST, S. J., AND REHDER, K.: Muscarinic receptor subtypes in canine trachea. Am. J. Physiol. 258: L349-L354, 1990.
48. BROCK, J. A. AND CUNNANE, T. C.: Electrophysiology of neuroeffector transmission in smooth muscle. In Autonomic neuroeffector mechanisms, ed. by G. Burnstock and C. H. V. Hoyle, pp. 121-213, Harwood Academic Publishers, USA, 1992.
49. BROWN, D. A., FORWARD, A., AND MARSH, S.: Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br. J. Pharmacol. 71: 362-364, 1980.
50. BRUNING, T. A., CHANG, P. C., HENDRIKS, M. G. C., VERMEIJ, P., PFAFFENDORF, M., AND VAN ZWIETEN, P. A.: In vivo characterization of muscarinic receptor subtypes that mediate vasodilatation in patients with essential hypertension. Hypertension 26: 70-77, 1995.
51. BRUNING, T. A., HENDRIKS, M. G. C., CHANG, P. C., KUYPERS, E. A. P., AND VAN ZWIETEN, P. A.: In vivo characterization of vasodilating muscarinic-receptor subtypes in humans. Circ. Res. 74: 912-919, 1994.
52. BRUNNER, F.: Subclassification of a trial and intestinal muscarinic receptors of the rat - direct binding studies with agonists and antagonists. Br. J. Pharmacol. 97: 572-578, 1989.
53. BRUNNER, F., WAELBROECK, M., AND CHRISTORPHE, J.: Secoverine is a nonselective muscarinic antagonist on rat heart and brain receptors. Eur. J. Pharmacol. 127: 17-25, 1986.
54. BUCKLEY, N. AND BURNSTOCK, G.: Autoradiographic localisation of muscarinic receptors in guinea-pig intestine: distribution of low and high affinity sites. Brain Res. 294: 15-22, 1984.
55. 3H] pirenzepine. Brain Res. 375: 83-91, 1986.
56. BUCKLEY, N. J. AND CAULFIELD, M. P: Transmission: acetylcholine. In Autonomic Neuroeffector Mechanisms, ed. by G. Burnstock and C. H. V. Hoyle, pp. 265-322, Harwood Academic Publishers, USA, 1992.
57. BURGEN, A. S. V.: The background of the muscarinic system. Life Sci. 56: 801-806, 1995.
58. 3H]-propylbenzilylcholine mustard by longitudinal strips from guinea-pig small intestine. Br. J. Pharmacol. 50: 145-151, 1974.
59. BURNSTOCK, G.: Structure of smooth muscle and its innervation. In Smooth Muscle, ed. by E. Bulbring, A. F. Brading, A. F. Jones and T. Tomita, pp. 1-70, Edward Arnold, London, 1970.
60. CAINE, M., RAZ, S., AND ZEIGLER, M.: Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br. J. Urol. 47: 193-202, 1975.
61. CANDELL, L. M., YUN, S. H., TRAN, L. L. P., AND EHLERT, F. J.: Differential coupling of subtypes of the muscarinic receptor to adenylyl cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum. Mol. Pharmacol. 38: 689-697, 1990.
62. CAREY, H. V., TIEN, X-Y., WALLACE, L. J., AND COOKE, H. J.: Muscarinic receptor subtypes mediating the mucosal response to neural stimulation of guinea-pig ileum. Am. J. Physiol. 253: G323-G328, 1987.
63. CARTER, J. P., NORONHA-BLOB, L., AUDIA, V. H., DUPONT, A. C., MCPHERSON, D. W., NATALIE, K J., RZESZOTARSKI, W. J., SPAGNUOLO, C. J., WAID, P. P., AND KAISER, C.: Analogues of oxybutynin: synthesis and antimuecarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds. J. Med. Chem. 34: 3065-3074, 1991.
64. CAULFIELD, M. P.: Muscarinic receptors - characterization, coupling and function. Pharmacol. Therap. 58: 319-379, 1993.
65. CAULFIELD, M. P., PALAZZI, E., LAZARENO, S. H., JONES, S., POPHAM, A., AND BIRDSALL, N. J. M.: Lack of significant selectivity of 'benzyl-4-DAPine' between four muscarinic receptor subtypes, binding and functional studies (Abstract). Br. J. Pharmacol. 108: 29P, 1993.
66. 1-selective muscarinic receptor antagonist, in patients with nocturnal asthma. Pulmon. Pharmacol. 7: 91-97, 1994.
67. CHEN, Q., YU, P., DE PETRIS, G., BIANCANI, P., AND BEHAR, J,: Distinct muscarinic receptors and signal transduction pathways in gallbladder muscle. J. Pharm. Exp. Ther. 273: 650-655, 1995.
68. 2 receptors. Br. J. Pharmacol. 114: 1507-1517, 1995.
69. 3H] quinuclidinyl benzilate binding in atrial and ileal longitudinal muscle of the guinea-pig. J. Pharm. Pharmacol. 37: 656-658, 1986.
70. CHOO, L. K. AND MITCHELSON, F.: Characterization of the antimuscarinic effect of heptane-1,7-bis-(dimethyl-3′-phthalimidopropyl ammonium bromide). Eur. J. Pharmacol. 162: 429-435, 1989.
71. 2 receptors modulate relaxant responses to isoproterenol in rat urinary bladder. (Abstract) Life Sci., in press.
72. 2 muscarinic receptors. Mol. Pharmacol. 46: 105-114, 1994.
73. CLAGUE, R. U., EGLEN, R. M., STRACHAN, A. C., AND WHITING, R. L.: Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro. Br. J. Pharmacol. 86: 163-170, 1985.
74. CLARK, A. L. AND MITCHELSON, F.: The inhibitory effect of gallamine on muscarinic receptors. Br. J. Pharmacol. 58: 323-331, 1976.
75. CUQ, P., MAGOUS, R., AND BALI, J. P.: Pharmacological coupling and functional role for the muscarinic receptor subtypes in isolated cell from the circular muscle of the rabbit cecum. J. Pharmacol. Exp. Ther. 271: 149-155, 1994.
76. D'AGOSTINO, G., BARBIERI, A., GRANA, E., AND SUBISSI, A.: Characterization of pre-junctional muscarinic autoreceptors in the rat urinary bladder. (Abstract) Life Sci. 52: 580, 1993.
77. 3H]-acetylcholine release in the rat urinary bladder. J. Pharmacol. Exp. Ther. 239: 522-528, 1986.
78. 3 muscarinic receptors in rat parotid gland couple to two second messenger systems. Am. J. Physiol. 261: C1063-C1073, 1991.
79. DAIL, W. D.: Autonomic innervation of male reproductive genitalia. In Nervous Control of the Urogenital System, ed. by C. A. Maggi, pp. 69-101, Harwood Academic Publishers, USA, 1993.
80. DALE, H. H.: The action of certain esters and ethers of choline and their relation to muscarine. J. Pharmacol, Exp. Ther. 6: 147-190, 1914.
81. DALE, H. H.: Nomenclature of fibres in the autonomic nervous system and their effects. J. Physiol. 80: 10-11P, 1933,
82. DARROCH, S. A., GARDNER, A., VONG, Y. M., CHOO, L. K., AND MITCHELSON, F.: Effect of temperature reduction on responsiveness to cholinomimetics in the taenia caeci of the guinea-pig. J. Auton. Pharmacol. 11: 109-119, 1991.
83. DAUPHIN, F. AND HAMEL, E.: Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature. J. Pharmacol. Exp. Ther. 260: 660-667, 1992.
84. DAUPHIN, F., LINVILLE, D. G., AND HAMEL, E.: Cholinergic dilatation and constriction of feline cerebral blood vessels are mediated by stimulation of phosphoinositide metabolism via two different muscarinic receptor sub-types. J. Neurochem. 63: 544-551, 1994.
85. DAUPHIN, F. AND MACKENZIE.: Cholinergic and vasoactive intestinal polypeptidergic innervation of the cerebral arteries. Pharmacol. Ther. 67: 385-417, 1995.
86. DAVISON, J. S., GREENWOOD, B., NAJAFI-FARASHAH, A., AND READ, N. W.: The effects of atropine and secoverine on gastric secretion and motility in the mouse isolated stomach. Br. J. Pharmacol. 79: 525-529, 1983.
87. DELTACCA, M., DANESI, R., BLANDIZZI, C., AND BERNARDINI, M. C.: Differential affinities of AF-DX116, atropine and pirenzepine for muscarinic receptors of guinea-pig gastric fundus, atria and urinary bladder might atropine distin-guish among muscarinic receptor subtypes? Pharmacol. 40: 241-249, 1990.
88. 3 muscarinic receptors in the circular muscle of the guinea-pig ileum. Naunyn Schmiedebergs Arch. Pharmacol. 351: 237-243, 1995.
89. DOGGRELL, S. A.: On the assessment of the potency of antagonists using the rat isolated anococcygeus muscle. J. Pharmacol. Methods 10: 243-254, 1983.
90. 2-muscarinic receptors in the epididymal half of the rat vas deferens. Gen. Pharmacol. 17: 239-241, 1986.
91. 1-m5) expressed in baculovirus-infected insect cells. J. Pharmacol. Exp. Ther. 274: 378-384, 1995.
92. DOODS, H. N.: Selective muscarinic antagonists as bronchodilators. Drug News and Perspectives 5: 345-352, 1992.
93. DOODS, H., ENTZEROTH, M., AND MAYER, N.: Cardioselectivity of AQ-RA 741, a novel tricyclic antimuscarinic drug. Eur. J. Pharmacol. 192: 147-152, 1991.
94. DOODS, H. N., ENTZEROTH, M., ZIEGLER, H., MAYER, N., AND HOLZER, P.: Pharmacological profile of selective muscarinic receptor antagonists on guinea-pig ileal smooth muscle. Eur. J. Pharmacol. 253: 275-281, 1994.
95. 3 binding sites. Eur. J. Pharmacol. 161: 215-218, 1989.
96. DOODS, H. N., WILLIM, K D., BODDEKE, H. W. G. M., AND ENZTEROTH, M.: Characterization of muscarinic receptors in guinea-pig uterus. Eur. J. Pharmacol. 260: 223-230, 1993.
97. DÖRJE, F., FRIEBE, T., TACKE, R., MUTSCHLER, E., AND LAMBRECHT, G.: Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus. Naunyn Schmiedebergs Arch. Pharmacol. 342: 284-289, 1990.
98. 1-m5) in rabbit peripheral tissues. Mol. Pharmacol. 40: 459-462, 1991a.
99. DÖRJE, F., WESS, J., LAMBRECHT, G., TACKE, R., MUTSCHLER, E., AND BRANN, M. R: Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 256: 727-733, 1991b.
100. DOROFEEVA, N. A., SHELKOVNIKOV, S. A., STARSHINOVA, L. A., DANILOV, A. F., NEDOMA, J., AND TUCEK, S.: Quest for agonist and antagonist selectivity at muscarinic receptors in guinea-pig smooth muscles and cardiac atria. Naunyn Schmiedebergs Arch. Pharmacol. 346: 383-390, 1992.
101. DOWNIE, J. W., TWIDDY, D. A. S., AND AWAD, S. A: Antimuscarinic and non-competitive properties of dicyclomine hydrochloride in isolated human and rabbit bladder muscle. J. Pharmacol. Exp. Ther. 201: 662-668, 1977.
102. DUCKLES, S. P.: Vascular muscarinic receptors: pharmacological characterization in the bovine coronary artery. J. Pharmacol. Exp. Ther. 246: 929-934, 1988.
103. DURANT, P. A. C., SHANKLEY, N. P., WELSH, N. J., AND BLACK, J. W.: Pharmacological analysis of agonist-antagonist interactions at acetylcholine muscarinic receptors in a new urinary bladder assay. Br. J. Pharmacol. 104: 146-150, 1991.
104. EGLEN, R. M., ADHAM, N. AND WHITING, R. L.: Acute desensitization of muscarinic receptors in the isolated guinea-pig ileal longitudinal muscle. J. Auton. Pharmacol. 12: 137-148, 1992c.
105. EGLEN, R. M., CORNETT, C. M., AND WHITING, R. L.: Interaction of p-F-HHSiD (p-Fluoro-hexahydrosila-difenidol) at muscarinic receptors in guinea-pig trachea. Naunyn Schmiedebergs Arch. Pharmacol. 342: 394-399, 1990a.
106. EGLEN, R. M., FORD, A. P. D. W., LEVINE, W, B., HARRIS, G. C., MICHEL, A. D., AND WHITING, R. L.: Multidisciplinary analysis of muscarinic receptors in guinea-pig isolated ileum, atria and uterus in vitro. In Trends in Receptor Research, ed. by P. Angeli, U. Gulini and W. Quaglia, pp. 273-293, Elsevier Science Publishers, 1992a
107. 3 receptors in guinea-pig ileum and atria in vitro. Br. J. Pharmacol. 109: 946-952, 1993a.
108. EGLEN, R. M. AND HARRIS, G. C.: Muscarinic receptor protection studies in isolated functional preparations (Abstract). Life Sci. 52: 571, 1993b.
109. EGLEN., R. M., HARRIS, G. C., COX., H., SULLIVAN, A. O., STEFANICH, E., AND WHITING, R. L.: Characterization of the interaction of the cervane alkaloid, imperialine, at muscarinic receptors in vitro. Naunyn Schmiedeberge Arch. Pharmacol. 346: 144-151, 1992b.
110. EGLEN, R M., HARRIS, G. C., TAYLOR, M., PFISTER, J. R., AND WHITING, R. L.: Characterization of muscarinic receptors mediating release of epithelial derived relaxant factor (EpDRF) in guinea-pig isolated trachea. Naunyn Schmiedebergs Arch. Pharmacol. 344: 29-35, 1991.
111. EGLEN, R. M., KENNY, B. A., MICHEL, A. D., AND WHITING, R. L.: Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification. Br. J. Pharmacol. 90: 693-700, 1987.
112. EGLEN, R. M., MICHEL, A. D., MONTGOMERY, W. W., KUNYSZ, E. A., MACHADO, C. A., AND WHITING, R. L.: The interaction of parafluorohexahydrosiladifenidol at muscarinic receptors in vitro. Br. J. Pharmacol. 99: 637-642, 1990b.
113. EGLEN, R. M., MICHEL, A. D., AND WHITING, R. L.: Characterization of the muscarinic receptor subtype mediating contractions of the guinea-pig uterus. Br. J. Pharmacol. 96: 497-499, 1989.
114. EGLEN R. M., MONTGOMERY W. W., DAINTY I. A., DUBUQUE L. K., AND WHITING R. L.: The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro. Br. J. Pharmacol. 95: 1031-1038, 1988.
115. 3-adrenoceptors in isolated oesophageal muscularis mucosae of the rat. Br. J. Pharmacol., 119: 595-601, 1996a.
116. EGLEN, R. M., PULIDO-RIOS, M. T., WEBBER, A. P., LEUNG, E., AND HEGDE, S. S.: Characterization of the interaction of darifenacin at muscarinic receptor subtypes in vitro. Br. J. Pharmacol., 118: 35P, 1996b.
117. EGLEN, R. M., REDDY, H., AND WATSON, N.: Selective inactivation of muscarinic receptor subtypes. Int. J. Biochem. 26: 1357-1368, 1994a.
118. EGLEN, R. M., REDDY, H., WATSON, N., AND CHALLISS, R. A. J.: Muscarinic receptor subtypes in smooth muscle. Trends Pharmacol. Sci. 15: 114-117, 1994b.
119. EGLEN, R. M., AND WATSON, N.: Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol. 78: 59-68, 1996.
120. EGLEN, R. M. AND WHITING, R. L.: Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature. J. Auton. Pharmacol. 5: 323-346, 1986.
121. EGLEN, R. M. AND WHITING, R. L.: Comparison of the muscarinic receptors of the guinea-pig oesophageal muscularis mucosae and trachea in vitro. J. Auton. Pharmacol. 8: 181-189, 1988.
122. EGLEN, R. M. AND WHITING, R. L.: Heterogeneity of vascular muscarinic receptors. J. Auton. Pharmacol. 19: 233-245, 1990.
123. 2 muscarinic receptors in the guinea-pig ileum. Life Sci. 56: 965-971, 1995.
124. EHLERT, F. J., OLIFF, H. S., AND GRIFFIN, M. T.: The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor. J. Pharmacol. Exp. Ther. 276: 405-410, 1996.
125. EL-KASHEF, H. AND CATRAVAS, J. D.: The nature of the muscarinic receptor subtypes mediating pulmonary vasoconstriction in the rabbit. Pulm, Pharmacol. 4: 8-19, 1991.
126. 2-adrenoceptors. Br. J. Pharmacol. 116: 166P, 1996.
127. ELNATAN, A. AND MITCHELSON, F.: The interaction of McN-A-343 with muscarine receptors in cardiac and smooth muscle. Biochem. Pharmacol. 46: 993-1003, 1993.
128. 4 receptors in vagally stimulated contractions of rabbit bronchus/ trachea. Pulm. Pharmacol. 7: 109-120, 1994.
129. ELTZE, M., ULLRICH, B., MUTSCHLER, E., MOSER, U., BUNGARDT, E., FRIEBE, T., GUBITZ, C., TACKE, R., AND LAMBRECHT, G.: Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney. Eur. J. Pharmacol. 238: 343-355, 1993.
130. 3H]AF-DX 384 to rat ileal smooth muscle muscarinic receptors. J. Recept. Res. 11: 141-152, 1991.
131. ERIKSON-LAMY, K. A., KAUFMAN, P. L., AND POLANSKY, J. R.: Dissociation of cholinergic supersensitivity from receptor number in ciliary muscle. Invest. Opthalmol. 29: 600-605, 1991.
132. 3 muscarinic receptors in the rat peripheral lung. Biochem. Pharmacol. 52: 643-658, 1996.
133. ETHIER, M. F., SCHAEFER, O. P., SAMANT, N., YAMAGUCHI, H., AND MADISON, J. M.: Muscarinic receptor reserve for inhibition of cAMP accumulation in bovine trachealis cells. Am. J. Physiol. 270: L199-L207, 1996.
134. FEINBERG, M.: The problems of anticholinergic adverse effects in older patients. Drugs Aging 3: 335-348, 1993.
135. FELDER, C. C.: Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J. 8: 619-625, 1995.
136. 3-muscarinic receptor mediates prejunctional inhibition of noradrenaline release and the relaxation in cat femoral artery. J. Pharm. Pharmacol. 43: 644-649, 1991.
137. 2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J. Pharmacol. Exp. Ther. 262: 119-126, 1992.
138. FISHER, S. K.: Homologous and heterologous regulation of receptor-stimulated phosphoinositide hydrolysis. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 288: 231-250, 1995.
139. FORD, A. P. D. W., LEVINE, W. B., BAXTER, G. S., HARRIS, G. C., EGLEN, R. M., AND WHITING, R. L.: Pharmacological, biochemical and molecular character-ization of muscarinic receptors in the guinea-pig ileum: a multidisciplinary study. Mol. Neuropharmacol. 1: 117-127, 1991.
140. FRYER, A. D. AND MACLAGAN, J.: Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br. J. Pharmacol. 83: 973-978, 1984.
141. 2 muscarinic receptors (Abstract). Am. J. Respir. Crit. Care Med. 153: A844, 1996.
142. FUDER, H.: Functional consequences of pre-junctional receptor activation or blockade in the iris. J. Ocul. Pharmacol. 10: 109-123, 1994.
143. FRYER, A. D. AND EL-FAKAHANY, E. E.: Identification of three muscarinic receptor subtypes in rat lung using binding studies with selective antagonists. Life Sci. 47: 611-618, 1990.
144. 3H] nor adrenaline release in rat or guinea-pig iris and the contraction of rabbit iris sphincter muscle. Naunyn Schmiedebergs Arch. Pharmacol. 340: 597-604, 1989.
145. FUKUDA, K., KUBO, T., MAEDA, A., AHBA, I., BUJO, H., NAKAI, J., MISHINA, M., HIGASHIDA, H., NEHER, E., MARTY, A., AND NUMA, S.: Selective effector coupling of muscarinic acetylcholine receptor subtypes. Trends Pharmacol. Sci. Dec. (suppl. IV): 4-10, 1989.
146. FURCHGOTT, R. F., AND BURSZTYN, P.: Comparison of dissociation constants and of relative efficacies of selected agonists acting at parasympathetic receptors. Ann. N. Y. Acad. Sci. 144: 882-898, 1967.
147. GARCIA-VILLALON, A., KRAUSE, D. N., EHLERT, F. J., AND DUCKLES, S. P.: Heterogeneity of muscarinic receptor subtypes in cerebral blood vessels. J. Pharmacol. Exp. Ther. 258: 304-310, 1991.
148. GARSSEN, J., VAN LOVEHEN, H., GIERVELD, C. M., VAN DER VLIET, H., AND NIJKAMP, F. P.: Functional characterization of muscarinic receptors in murine airways. Br. J. Pharmacol. 109: 53-60, 1993.
149. GATHERS, C. M., COLBERT, W. E., AND BERGER, J. E.: Characterization of muscarinic receptors on the isolated guinea-pig ileum at pharmacologically low concentrations. Gen. Pharmacol. 24: 659-661, 1993.
150. GHELARDINI, C., BARTOLINI, A., GALEOTTI, N., TEODORI, E., AND GUALTIERI, F.: S-(-)-ET 126: a potent and selective M1 antagonist in vitro and in vivo. Life Sci. 58: 991-1000, 1996.
151. GIES, J. P., BERTRAND, C., VANDERHEYDEN, P., WAELDELE, F., DUMONT, P., PAULI, G., AND LANDRY, Y.: Characterization of muscarinic receptors in human, guinea-pig and rat lung. J. Pharmacol. Exp. Ther. 250: 309-315, 1989.
152. GILANI, S. A. H. AND COBBIN, L. B.: The cardio-selectivity of himbacine: a muscarinic receptor antagonist. Naunyn Schmiedebergs Arch. Pharmacol. 332: 16-20, 1986.
153. GILBERT, R., RATTAN, S., AND GOYAL, R. K.: Pharmacologic identification, activation and antagonism of two muscarine receptor subtypes in the lower esophageal sphincter. J. Pharmacol. Exp. Ther. 230: 284-291, 1984.
154. GILLBERG, P-G., MODIRI, A. R., AND SPARF, B.: Tolteridine - a new agent with tissue selectivity for urinary bladder. (Abstract) Neurourol. Urodyn. 13: 435-436, 1994.
155. GILLESPIE, J. S.: The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br. J. Pharmacol. 45: 404-416, 1972.
156. GIRALDO, E., MONFERINI, E., LADINSKY, H., AND HAMMER, R.: Muscarinic receptor heterogeneity in guinea-pig intestinal smooth muscles: binding studies with AF-DX 116. Eur. J. Pharmacol. 141: 475-477, 1987.
157. GIRALDO, E., VIGANO, M. A., HAMMER, R AND LADINSKY, H.: Characterization of muscarinic receptors in guinea-pig ileum longitudinal smooth muscle. Mol. Pharmacol. 33: 617-625, 1988.
158. GOMEZ, A., MARTOS, F., BELLIDO, I., MARQUEZ, E., GARCIA, A. J, PAVIA, J., AND SANCHEZ DE LA CUESTA, F.: Muscarinic receptor subtypes in human and rat colon smooth muscle. Biochem. Pharmacol. 43: 2413-2419, 1992.
159. GONZALES, G. F.: Functional structure and ultrastructure of seminal vesicles. Arch. Androl. 22: 1-13, 1989.
160. GOYAL, R. K. AND RATTAN, S.: Neurohormonal, hormonal and drug receptors for the lower oesophageal sphincter. Gastroenterology 74: 598-619, 1978.
161. GRANA, E., LUCCHELLI, A., ZONTA, F., AND BOSELLI, C.: Determination of dissociation constants and relative efficacies of some potent muscarinic agonists at post-junctional muscarinic receptors. Naunyn Schmiedebergs Arch. Pharmacol. 335: 8-11, 1987.
162. GRANDORDY, B. M., Cuss, F. M., SAMPSON, A. S., PALMER, J. B., AND BARNES, P. J.: Phosphatidylinositol response to cholinergic agonists in airway smooth muscle: relationship to contraction and muscarinic receptor occupancy. J. Pharmacol. Exp. Ther. 238: 273-279, 1986.
163. 2 receptors on single muscle cells of the human and guinea-pig intestine. Gastroenterology 93: 951-957, 1987.
164. 2 muscarinic receptors in rat intestinal smooth muscle. J. Pharmacol. Exp. Ther. 263: 221-225, 1992.
165. GRIFFIN M. T., THOMAS E. A., AND EHLERT F. J.: Kinetics of activation and in vivo muscarinic receptor binding of N-(2-bromoethyl)-4-piperidinyl diphenylacetate: an analog of 4-DAMP mustard. J. Pharmacol. Exp. Ther. 266: 301-305, 1993.
166. GRIMM, U., MOSER, U., MUTSCHLER, E., AND LAMBRECHT, G.: Muscarinic
167. GROSS, N. J. AND SKORODIN, M. S.: Anticholinergic antimuscarinic bronchodilators. Am. Rev. Respir. Dis. 129: 856-870, 1984.
168. GUNST, S. J., STROPP, J. Q., AND FLAVAHAN, N. A.: Muscarinic receptor reserve and β-adrenergic sensitivity in tracheal smooth muscle. J. Appl. Physiol. 67: 1294-1298, 1989.
169. HADDAD, E. B., LANDRY, Y., AND GIES, J.-P.: Muscarinic receptor subtypes in guinea-pig airways. Am. J. Physiol. 261: L327-L333, 1991.
170. HADDAD, E. B., MAK, J. C. W., HISLOP, A., HAWORTH, S. G., AND BARNES, P. J.: Characterization of muscarinic receptor subtypes in pig airways: radioligand binding and Northern blotting studies. Am. J. Physiol. 266: L642-L648, 1994.
171. 3H]Ba 679 Br, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping. Mol. Pharmacol. 45: 899-907, 1994.
172. Ca) function (Abstract). Am. J. Respir. Crit. Care Med. 153: A380, 1996.
173. HAKONARSON, H., HERRICK, D. J., AND GHUNSTEIN, M. M.: Mechanism of impaired β-adrenoceptor responsiveness in atopic sensitized airway smooth muscle. Am. J. Physiol. 269: L645-L652, 1995.
174. 3 receptor stimulation in guinea-pig coronary artery. Br. J. Pharmacol. 115: 717-722, 1995.
175. HAMMER, R.: Muscarinic receptors in the stomach. Scand. J. Gastoenterol. 66(suppl.): 5-11, 1980.
176. HAMMER, R., BERRIE, C. P., BIRDSALL, N. J. M., BURGEN, A. S. V., AND HULME, E. C.: Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature (Lond.) 283: 90-92, 1980.
177. 2 biochemical and functional characterization. Life Sci. 31: 2991-2998, 1982.
178. HAMMER, R., GIRALDO, E., SCHIAVI, G. B., MONFERINI, E., AND LADINSKY, H.: Binding profile of a novel cardioselective muscarinic receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci. 38: 1653-1662, 1986.
179. 3 receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells. J. Urol. 154: 1241-1245, 1995.
180. 3 muscarinic receptors in mediating reflex bladder contractions in the anaesthetized rat. Br. J. Pharmacol., 118: 45P, 1996.
181. HELANDER, K G., BAMBERG, R, SACHS, G., MELLE, D., AND HELANDER, H. F.: Localization of mRNA for the M1 receptor in rat stomach. Biochim. Biophys. Acta 1312: 168-162, 1996.
182. HELDMAN, E., BARG, J., FISHER, A., LEVY, R., PITTEL, Z., ZIMLICHMAN, R., KUSHNIR, M., AND VOGEL, Z.: Pharmacological basis for functional selectivity of partial muscarinic receptor agonists. Eur. J. Pharmacol. 297: 283-291, 1996.
183. HENDRICKS, M. G., PFAFFENDORF, M., AND VAN ZWIETEN, P. A.: Characterization of the muscarinic receptors in the mesenteric bed of spontaneously hypertensive rats. J. Hypertens. 11: 1329-1335, 1993.
184. HENDRIX, T. R.: Coordination of peristalsis in pharynx and esophagus. Dysphagia 8: 74-78, 1993.
185. 2 receptor subtypes for agonists and antagonists in porcine gastric smooth muscle and mucosa. Gastroenterol. J. 94: 630-637, 1988.
186. HERNANDEZ, M., SIMONSEN, U., PRIETO, D., RIVEKA, L., GARCIA, P., ORDAZ, E., AND GARCIA-SACRISTAN, A.: Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated ureter. Br. J. Pharmacol. 110: 1413-1420, 1993.
187. HERNANDEZ, M., GARCIA-SACRISTAN, A., AND ORENSANZ, L. M.: Muscarinic binding sites of the pig intravesical ureter. J. Auton, Pharmacol. 15: 351-369, 1995.
188. HIEBLE, J. P., MCCAFFERTY, G. P., NASELSKY, D. P., BERGSMA, D. J., AND RUFFOLO, R. R.: Recent progress in the pharmacotherapy of diseases of the urinary tract. Eur. J. Med. Chem. 30: 269-298, 1995.
189. HIRSCHOWITZ, B. I., KEELING, D., LEWIN, M., OKABE, S., PARSONS, M., SEWING, K, WALLMARK, B., AND SACHS, G.: Pharmacological aspects of acid secretion. Dig. Dis. Sci. 40: 3S-23S, 1995.
190. HOBBINGER, F., MITCHELSON, F., AND RAND, M. J.: The action of some cholinomimietic drugs on the isolated tania of the guinea-pig caecum. Br. J. Pharmacol. 36: 53-69, 1969.
191. HUDSON, N.: The nerves of the testis, epididymis and scrotum. In The Testis: Development, Anatomy and Physiology, ed. by W. R. Gomes and N. L. Vandemarkpp, vol. 1, pp. 47-99, New York Academic Press, USA, 1970.
192. HONDA, K., TAKANO, Y., AND KAMIYA, H.: Pharmacological profiles of muscarinic receptors in the longitudinal smooth muscle of guinea-pig ileum. Jpn. J. Pharmacol. 62: 43-47, 1993.
193. HONKANEN, R. E. AND ABDEL-LATIF, A. A.: Characterization of cholinergic muscarinic receptors in the rabbit iris. Biochem. Pharmacol. 37: 2575-2583, 1988.
194. 3 muscarinic receptor subtype predominates in the bovine iris sphincter smooth muscle and ciliary processes. Invest. Opthalmol. Vis. Sci. 31: 590-593, 1990.
195. HOSEY, M. M.: Diversity of structure, signaling and regulation within the family of muscarinic cholinergic receptors. FASEB J. 6: 845-852, 1992.
196. HOU, X., WEHRLE, J. M., CICCARELLI, E., WESS, J., MUTSCHLER, E., LAMBRECHT, G., TIMMERMAN, H., AND WAELBROECK, M.: Influence of monovalent cations on the binding of a charged and an uncharged ('carbo'-) muscarinic antagonist to muscarinic receptor. Br. J. Pharmacol. 117: 955-961, 1996.
197. HOWELL, R. E., LAEMONT, K. D., KOVALSKY, M. P., LOWE, V. C., WAID, P. P., KINNIER, W. J., AND NORONHA-BLOB, L.: Pulmonary pharmacology of a novel, smooth muscle-selective muscarinic antagonist in vivo. J. Pharm. Exp. Ther. 270: 546-555, 1994.
198. HOYLE, H. B., AND BURNSTOCK, G.: Postganglionic efferent transmission in the bladder and urethra. In Nervous Control of the Urogenital System, ed. by C. A. Maggi, pp. 349-381, Harwood Academic Publishers, USA, 1993.
199. HUA, X-Y., BACK, S. M., AND YAKSH, T. L.: Characterization of muscarinic receptors involved in tracheal CGRP release. Neuroreport 5: 2133-2136, 1994.
200. + channel blockers. Eur. J. Pharmacol. 235: 37-43, 1993.
201. 1 receptor-selective agents. Eur. J. Pharmacol. 231: 485-488, 1993.
202. HUG, H. AND SARRE, T. F.: Protein kinase isoenzymes divergence in signal transduction. Biochem. J. 291: 329-343, 1993.
203. HULME, E. C., BIRDSALL, N. J. M., AND BUCKLEY, N. J.: Muscarinic receptor subtypes. Ann, Rev. Pharmacol. Toxicol. 30: 633-673, 1990.
204. INOUE, R. AND ISENBERG, G.: Acetylcholine activates nonselective cation channels in guinea-pig ileum through a G protein. Am. J. Physiol. 298: C1173-C1178, 1990.
205. INOUE, R., KITAMURA, K., AND KITAYAMA, H.: Two Ca-dependent K-channels modified by the application of tetraetylammonium distribute to smooth muscle cell membranes of the rabbit portal vein. Pflugers Arch. 405: 173-179, 1985.
206. INOUE, T., OKASORA, T., AND OKAMOTO, E.: Effect on muscarinic acetylcholine receptors after experimental neuronal ablation in rat colon. Am. J. Physiol. 269: G940-G944, 1995.
207. JAEN, J. C. AND DAVIS, R. E.: Recent advances in the design and characterization of muscarinic agonists and antagonists. Annu. Rep. Med. Chem. 29: 23-32, 1994.
208. JAISWAL, N., LAMBRECHT, G., MUTSCHLER, E., TACKE, R., AND MALIK, K. U.: Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. J. Pharmacol. Exp. Ther. 258: 842-850, 1991.
209. 4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists. FEBS Lett. 377: 275-279, 1995.
210. JANSSEN, L. J. AND DANIEL, E. E.: Pre-and post-junctional muscarinic receptors in canine bronchi. Am. J. Physiol. 259: L304-L314, 1990.
211. JANSSEN, L. J. AND SIMS, S. M.: Acetylcholine activates non-selective cation and chloride conductances in canine and guinea-pig tracheal myocytes. J. Physiol. 453: 197-218, 1992.
212. JANSSEN, L. J. AND SIMS, S. M.: Spontaneous transient inward currents and rhythmicity in canine and guinea-pig tracheal smooth muscle cells. Pflugers Arch. 428: 473-480, 1994.
213. JOHNSON, J. M., SKAU, K. A., GERALD, M. C., AND WALLACE, L. J.: Regional noradrenergic and cholinergic neurochemistry in the rat urinary bladder: effects of age. J. Urol. 139: 611-615, 1988.
214. JOHNSON, P. J., BORNSTEIN, J. C., YUAN, S. Y., AND FURNESS, J. B.: Analysis of contributions of acetylcholine and tachykinins to neuro-neuronal transmission in motility reflexes in the guinea-pig ileum. Br. J. Pharmacol. 118: 973-983, 1996.
215. 4 receptors. FEBS Lett. 352: 91-94, 1994.
216. + channel inhibitor. J. Pharmacol. Exp. Ther. 258: 697-706, 1990.
217. JOVANOVIC, A., GRBOVIC, L., DREKIC, D., AND NOVAKOVIC, S.: Muscarinic receptor function in the guinea-pig uterine artery is not altered during preg-nancy. Eur. J. Pharmacol. 258: 185-194, 1994.
218. 3 muscarinic acetylcholine receptors in vitro, Mol. Pharmacol. 38: 836-840, 1990.
219. KAISER, C., AUDIA, V. H., CARTER, J. P., MCPHERSON, D. W., WAID, P. P., LOWE, V. C., AND NORONHA-BLOB, L.: Synthesis and antimuscarinic properties of some 1-cycloalkyl-1-hydroxy-1-phenyl-3-(4-substituted piperazinyl)-2- propanones and related compounds. J. Med. Chem. 6: 610-616, 1993.
220. 3H)-furanones. J. Med. Chem. 5: 4415-4424, 1992.
221. KAJIMURA, M., REUBEN, M. A., AND SACHS, G.: The muscarinic receptor gene expressed in rabbit parietal cells is the m3 subtype. Gastroenterology 103: 870-875, 1992.
222. KAMAI, T., FUKUMOTO, Y., GOUSSE, A, YOSHIDA, M., DAVENPORT, T. A., WEISS, R. M., AND LATIFPOUR, J.: Diabetes induced alterations in the properties of muscarinic cholinergic receptors in rat vas deferens. J. Urol. 152: 1017-1021, 1994.
223. KAMIKAWA, Y. AND SHIMO, Y.: Cholinergic and adrenergic innervation of the muscularia mucosae in guinea-pig esophagus. Arch. Int. Pharmacodyn. Ther. 238: 220-232, 1979.
224. KARAHAN, F., ALICAN, I., OZKUTLU, U., ONAT, F., YEGEN, B. C., ULUSOY, N. B., AND OKTAY, S.: Muscarinic receptor subtypes of the guinea-pig common bile duct. Arch. Int. Pharmacodyn. Ther. 312: 140-145, 1991.
225. KENAKIN, T. P., BOND, R. A., AND BONNER, T. I.: Definition of pharmacological receptors. Pharmacol. Rev. 44: 351-362, 1992.
226. KENAKIN, T. P. AND BOSELLI, C.: Promiscuous or heterogenous muscarinic receptors in rat atria? I. Schild analysis with simple competitive antago-nists. Eur. J. Pharmacol. 191: 39-48, 1990.
227. KERR, P. M., HILLIER K., WALLIS R. M., AND GARLAND C. J.: Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human colon. Br. J. Pharmacol. 115: 1518-1524, 1995.
228. KILBINGER, H., SCHNEIDER, R., SIEFKIN, H., WOLF, D., AND D'AGOSTINO, G.: Characterization of the prejunctional muscarinic autoreceptor in the guinea-pig trachea. Br. J. Pharmacol. 103: 757-763, 1991.
229. KILBINGER, H., VON BARDELEBEN, R. S., SIEFKEN, H., AND WOLF, D.: Prejunctional muscarinic receptors regulating neurotransmitter release in airways. Life Sci. 58: 981-987, 1995.
230. KIM, N., AZADZOI, K M., GOLDSTEIN, I., AND SAENZ DE TEJADA, I.: A nitric oxide-like factor mediates nonadrenergic-noncholinergic relaxation of penile cavernosum smooth muscle. J. Clin. Inv. 88: 112-118, 1991.
231. KIRKUP, A. J. AND MOORE, B. A.: Characterisation of the muscarinic receptor subtypes mediating salivary gland secretion and tracheal smooth muscle contraction in the rat. Br. J. Pharmacol. 115: 140P, 1995.
232. KNISPEL, H. H., GOESSL, C., AND BECKMANN, R.: Nitric oxide mediates relaxation in rabbit and human corpus cavernosum smooth muscle. Urol. Res. 20: 253-287, 1992.
233. KONDA, S., TASHIMA, Y., AND MORITA, T.: Segmental differences in the density of autonomic receptors in dog vas deferens. Urol. Int. 53: 62-67, 1994.
234. KONDO, S., MORITA, T., AND HIRANO: A study of the affinities of various muscarinic antagonists to the human detruaor muscle. J. Smooth Muscle Res. 29: 63-68, 1993.
235. KONDO, S., MORITA, T., AND TASHIMA, Y.: Muscarinic cholinergic receptor subtypes in human detrasor muscle studied by labelled and non-labelled pirenzepine, AF-DX116 and 4-DAMP. Urol. Inter. 54: 150-153, 1995.
236. 3 receptors coupled to phosphoinositide metabolism. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 172: 397-405, 1989.
237. KOSS, M. C. AND WALLY, J. R.: Analysis of miosis produced by McN-A-343 in anesthetized cats. J. Ocul. Pharmacol. Ther. 11: 389-399, 1995.
238. + channels by guanine-nucleotide binding protein. Proc. Natl. Acad. Sci. USA 89: 11051-11055, 1992.
239. 2+ channels in airway smooth muscle by a pertussis toxin-sesntive G-protein. Am. J. Physiol. 261: 1204-1209, 1991.
240. KURTEL, H., YEGEN, B. C., DEDEOGLU, A., ULUSOY, N. B., AND OKTAY, S.: Muscarinic receptor subtype of guinea-pig gallbladder smooth muscle. Arch. Int. Pharmacodyn. Ther. 80: 39-46, 1990.
241. LAD, R., DONOFF, B., AND RANGACHARI, P. K: Functional subtyping of muscarinic receptors on canine esophageal mucosa. Am. J. Physiol. 261: G464-469, 1991.
242. 2 muscarinic acetylcholine receptors are coupled to multiple signalling pathways via pertussis-toxin sensitive guanine nucleotide regulatory pro-teins. J. Pharmacol. Exp. Ther. 256: 938-944, 1991.
243. 3H] phorbol 12, 13 dibutyrate binding sites in mouse neuroblastoma cells and simultaneous down-regulation by phorbol esters of muscarinic receptor function. J. Pharmcol. Exp. Ther. 244: 41-50, 1988.
244. LAMBRECHT, G., FEIFEL, R., MOSER, U., WAGNER-RODER, M., CHOO, L. K., CAMUS, J., TASTENOY, M., WAELBROECK M., STROHMANN, C., TACKE, R., RODRIGUES DE MIRANDA, J. F., CHRISTORPHE J. AND MUTSCHLER, E.: Pharmacology of hexahydro-difenidol, hexahydro-sila-difenidol and related selective muscarinic antagonists. Trends Pharmacol. Sci. 8(suppl.): 60-64, 1989a.
245. LAMBRECHT, G., FEIFEL, R., WAGNER-ROSDER, M., STROHMANN, C., ZILCH, H., TACKE, R., WAELBROECK, M., CHRISTORPHE, J., BODDEKE, H., AND MUT-SCHLER, E: Affinity profile of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur. J. Pharmacol. 168: 71-80, 1989b.
246. 2β-selective muscarinic antagonist. Eur. J. Pharmacol. 62: 193-194, 1988.
247. LATIFPOUR, J., GOUSSE, A., KONDO, S., MORITA, T., AND WEISS, R. M.: Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors. J. Pharmacol. Exp. Ther. 248: 81-88, 1989.
248. LATIFPOUR, J., KONDA, S., O' HOLLAREN, B., MORITA, T., AND WEISS, R. M.: Autonomic receptors in the urinary tract: sex and age differences. J. Pharmacol. Exp. Ther. 253: 661-667, 1990.
249. LATIFPOUR, J., NISHIMOTO, T., MARIAN, M. J., YOSHIDA, M., AND WEISS, R. M: Differential regulation of bladder β-adrenergic and muscarinic cholinergic receptors in experimental animals. Diabetes 40: 1150-1156, 1991.
250. 4 binding sites in rabbit lung, chicken heart and NG 108-15 cells. Mol. Pharmacol. 38: 805-815, 1990.
251. 2-subtype selective antagonists. Br. J. Pharmacol. 98: 309-317, 1989.
252. LEE, N. H., AND EL-FAKAHANY E. E.: The allosteric binding profile of him-bacine: a comparison with other cardioselective muscarinic antagonists. Eur. J. Pharmacol. 179: 225-229, 1990.
253. LEIBER, D., MARC, S., AND HARBON, S.: Pharmacologic evidence for distinct muscarinic receptor subtypes coupled to the inhibtion of adenylate cyclase and to increased generation of inositol phospholipids in the guinea-pig myometrium. J. Pharmacol. Exp. Ther. 52: 800-809, 1990.
254. LEIBMANN, C., NAWRATH, S., SCHNITTLER, M., SCHUBERT, H., AND JAKOBS, K. H.: Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes. Naunyn Schmiedebergs Arch. Pharmacol. 345: 7-15, 1992.
255. LEPOR, H., GUP, D., SHAPIRO, E., AND BAUMANN, M.: Muscarinic cholinergic receptors in the normal and neurogenic human bladder. J. Urol. 142: 869-874, 1989.
256. LEPOR, H. AND KUHAR, M. J.: Characterization of muscarinic cholinergic receptor binding in the vas deferens, bladder, prostate and penis of the rabbit. J. Urol. 132: 392-396, 1984.
257. LEUNG, E. AND MITCHELSON, F. J.: The interaction of pancuronium with cardiac and ileal muscarinic receptors. Eur. J. Pharmacol. 80: 1-9, 1982.
258. LEVEY, A. I.: Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci. 52: 441-448, 1993.
259. LEVIN, R. M., HIGH, J., AND WEIN, A. J.: The effect of short term obstruction on urinary bladder function in the rabbit. J. Urol. 132: 789-791, 1984.
260. LEVIN, R. M., RUGGIERI, M. R., AND WEIN, A. J.: Identification of receptor subtypes in the rabbit and human urinary bladder by selective radioligand binding. J. Urol. 139: 844-848, 1988.
261. LI, C. K. AND MITCHELSON, F.: The selective antimuscarinic action of stercuronium. Br. J. Pharmacol. 70: 313-321, 1980.
262. LIM, S. P. AND BOLTON, T. B.: A calcium-dependent rather than a G protein mechanism is involved in the inward current evoked by muscarinic receptor stimulation in dialysed single smooth muscle cells of small intestine. Br. J. Pharmacol. 95: 325-327, 1988.
263. LINVILLE, D. G. AND HAMEL, E.: Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine microveesels. Naunyn Schmiedebergs Arch. Pharmacol. 352: 179-186, 1995.
264. LIU, M. AND SIMON, M. I.: Regulation by cAMP-dependent protein kinase of a G-protein-mediated phopholipase C. Nature (Lond.) 382: 83-87, 1996.
265. 3 muscarinic receptor antagonists inhibit smooth muscle contraction in rabbit trachea without increasing the release of acetylcholine. J. Pharmacol. Exp. Ther. 263: 773-779, 1992.
266. 3 antagonists on muscarinic receptors in rabbit trachea. Arch. Int. Pharmacol. Ther. 328: 225-234, 1994.
267. LONGHURST, P. A., LEGGETT, R. E., AND BRISCOE, J. A. K: Characterization of functional muscarinic receptors in the rat urinary bladder. Br. J. Pharmacol. 116: 2279-2285, 1995.
268. LOPEZ-BERNAL, A., EUROPE-FINNER, G. N., PHANEUF, S., AND WATSON, S. P.: Preterm labour: a pharmacological challenge. Trends Pharmacol. Sci. 16: 129-133, 1995.
269. LU, M. C., NOBLE, G. D., THOMPSON, E. B., AND VOGEL, S. M.: Molecular modification of anticholinergics as probes for muscarinic receptors. Part 4. Heal selective muscarinic antagonists. Drug Des. Deliv. 7: 269-278, 1991.
270. LUCCHESI, P. A., SCHEID, C. R., ROMANO, F. D., KARGACIN, M. E., MULLIKIN-KILPATERICK, D., YAMAGUCHI, H., AND HONEYMAN, T. W.: Ligand binding and G protein coupling of muscarinic receptors in airway smooth muscle. Am. J. Physiol. 258: C730-738, 1990.
271. LULICH, K. M., PATERSON, J. W., AND GOLDIE, R. G.: Ipratropium, sodium chromoglycate and antihistamines. Med. J. Aust. 162: 157-159, 1995.
272. LUNDBERG, J. M.: Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 48: 113-178, 1996.
273. MAEDA, A., KUBO, T., MASAYOSHI, M., AND SHOSAKU, N.: Tissue distribution of mRNA's encoding muscarinic acetylcholine receptor subtypes. FEBS Lett. 239: 339-342, 1988.
274. MAESEN, F. P. V., SMEETS, J. J., SLEDSENS, T. J. H., WALD, F. D. M., CORNELISSEN, P. J. G.: Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD), Eur. Respir. J. 8: 1506-1513, 1995.
275. MAGGI, C. A.: Nervous Control of the Urogenital System, Harwood Academic Publishers, USA, 1993.
276. MAGGIO, R., BARBIER, P., BOLOGNESI, M. L., MINARINI, A., TEDESCHI, D., AND MELCHIORRE, C.: Binding profile of the selective muscarinic receptor antag-onist tripitramine. Eur. J. Pharmacol 268: M459-M462, 1994.
277. MAHESH, V. K., NUNAN, L. M., HALONEN, M., YAMAMURA, H. I., PALMER, J. D., AND BLOOM, J. W.: A minority of muscarinic receptors mediate rabbit tracheal smooth muscle contraction. Am. J. Respir. Cell Mol. Biol. 6: 279-286, 1992.
278. MAK, J. C. W. AND BARNES, P. J.: Autoradiographic visualization of muscarinic receptor subtypes in human and guinea-pig lung. Am. J. Respir. Dis. 141: 1559-1568, 1990.
279. MAK, J. C. W., BARANIUK, J. N., AND BARNES, P. J.: Localization of muscarinic receptor subtype mRNAs in human lung. Am. J. Respir. Cell Mol. Biol. 7: 344-348, 1992.
280. MALARKEY, K., AIDUUS, D., BELHAM, C. M., GRAHAM, A., MCLEES, A., PAUL, A., AND PLEVIN, R.: Cell signalling pathways involved in the regulation of vascular smooth muscle and relaxation. In Pharmacology of Vascular Smooth Muscle, ed. by C. J. Garland and J. A. Angus, J. A., pp. 160-183, Oxford University Press, Oxford, UK, 1996.
281. MARC, S., LEIBER, D., AND HARBON, S.: Carbachol and oxytocin stimulate the generation of inositol phosphates in the guinea-pig myometrium. FEBS Lett. 201: 9-14, 1986.
282. MARC, S., LEIBER, D., AND HARBON, S.: Fluoroaluminates mimic muscarinic and oxytocin receptor mediated generation of inositol phosphates and contraction in the intact guinea-pig myometrium. Role for pertussis/cholera toxin sensitive G proteins. Biochem J. 255: 705-713, 1988.
283. MASUDA, Y., YAMAHARA, N. S., TANAKA, M., RYANG, S., KAWAI, T., IMAIZUMI, Y., AND WATANABE, M.: Characterization of muscarinic receptors mediating relaxation and contraction in the rat iris dilator muscle. Br. J. Pharmacol. 114: 769-776, 1995.
284. MATESIC, D. F., MANNING, D. R., AND LUTIN, G. R.: Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins. Mol. Pharmacol. 40: 347-353, 1991.
285. MATSUMOTO, S., YORIO, T., DE SANTIS, L., AND PANG, I-H.: Muscarinic effects on cellular functions in cultured human ciliary muscle cells. Invest. Opthalmol. Vis. Sci. 35: 3732-3738, 1994.
286. MATSUNO, K. AND MITA, S.: Involvement of the muscarinic receptors in the postsynaptic potentiation of neurogenic twitch contraction in the mouse vas deferens. Life. Sci. 50: 799-806, 1992.
287. MCCANN, J. D. AND WELSH, M. J.: Calcium-activated potassium channels in canine airway smooth muscle. J. Physiol. 372: 113-127, 1986.
288. MCCORMACK, D. G., MAK, J. C., MINETTE, P., AND BARNES, P. J.: Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery. Eur. J. Pharmacol. 158: 293-297, 1988.
289. MCINTYRE, P. AND QUINN, P.: Characterisation and comparison of muscarinic receptors in the dog ciliary muscle with ileum. Br. J. Pharmacol. 118: 139P, 1995.
290. MCRITCHIE, B., MEHNER, P. A., AND DODD, M. G.: In vivo selectivity of the novel muscarinic antagonist, zamifenacin, in the conscious dog. Br. J. Pharmacol. 109: 38P, 1993.
291. MELCHIORRE, C., ANGELI, P., LAMBRECHT, G., MUTSCHLER, E., PICCHIO, M. T., AND WESS, J.: Antimuscarinic action of methoctramine, a new cardioselective M-2 selective muscarinic receptor antagonist, alone and in combination with atropine and gallamine. Eur. J. Pharmacol. 144: 117-124, 1987.
292. 2 muscarinic receptor antagonists. J. Med. Chem. 36: 3734-3737, 1993.
293. MEURS, H., KAUFFMAN, H. F., KOETER, G. H., TIMMERMANS, A., AND DE VRIES, K.: Regulation of the beta-receptor adenylate cyclase system in lymphocytes of allergic patients with asthma: possible role for protein kinase C in allergen-induced nonspecific refractoriness of adenylate cyclase. J. All. Clin. Immunol. 80: 326-339, 1987.
294. MEURS, H., TIMMERMANS, A., VAN AMSTERDAM, R. G. M., BROUWER, F., KAUFFMAN, H. F., AND ZAAGSMA, J.: Muscarinic receptors in human airway smooth muscle are coupled to phosphoinositide metabolism. Eur. J. Pharmacol. 164: 369-371, 1989.
295. MICHALEK, H., FORTUNA, S., AND PINTOR, A.: Age-related changes in muscarinic receptor and post-receptor mechanisms in brain and ileum strip of rats. Acta Neurobiol. Exp. 53: 93-101, 1993.
296. MICHEL, A. D. AND WHITING, R. L.: Direct binding studies on ileal and cardiac muscarinic receptors. Br. J. Pharmacol. 92: 755-767, 1987.
297. 2 muscarinic receptors in longitudinal ileal smooth muscle membranes. Eur. J. Pharmacol. 145: 305-311, 1988.
298. 3H] 4-diphenylacetoxy-N-methyl piperidine methiodide to longitudinal ileal smooth muscle muscarinic receptors. Eur. J. Pharmacol. 176: 197-205, 1990.
299. 1 muscarinic receptors. J. Pharmacol. Exp. Ther. 263: 310-315, 1990.
300. MIMATA, H., WHEELER, M. A., FUKUMOTO, Y., TAKIGAWA, H., NISHMOTO, T., WEISS, R. M., AND LATIFPOUR, J.: Enhancement of muscarinic receptor-coupled phosphatidyl inositol hydrolysis in diabetic bladder. Mol. Cell. Biochem. 152: 71-76, 1995.
301. MIRANDA, H. F., BUSTAMANTE, D., CASTILLO, O., SALVATIERRA, P., SAAVEDRA, H., FERNANDEZ, E., PAEILE, C., PELISSIER, T., AND PINARDI, G.: Cholinergic receptors in the human vas deferens. J. Recept. Res. 12: 101-115, 1992.
302. MIRANDA, H. F., DURAN, E., BUSTAMANTE, D., PAELLE, C., AND PINARDI, G.: Preand post-junctional muscarinic receptor subtypes in the vas deferens of rat. Gen. Pharmacol. 25: 1643-1647, 1994.
303. MISLE, A. J., LIPPO DE BECEMBERG, I., GOZALES DE ALFONZO, R., AND ALFONZO, M. J.: Methoctramine binding sites sensitive to alkylation on muscarinic receptors from tracheal smooth muscle. Biochem. Pharmacol. 48: 191-195, 1994.
304. MITCHELL, R. W., KOENIG, S. M., POPOVICH, K. J., KELLY, E., TALLET, J., AND LEFF, A. R.: Pertussis toxin augments β-adrenergic relaxation of muscarinic contraction in canine trachealis. Am. Rev. Respir. Dis. 147: 327-331, 1993.
305. MITCHELSON, F.: Muscarinic receptor differentiation. Pharmacol. Ther. 37: 357-423, 1988.
306. MIURA, M., BELVISI, M. G., STRETTON, D., YACOUB, M. H., AND BARNES, P. J.: Role of potassium channels in human airway smooth muscle. Am. Rev. Respir. Dis. 146: 132-136, 1992.
307. MOLTZEN, E. K. AND BJORNHOLM, B.: Medicinal chemistry of muscarinic agonists developments since 1990. Drugs Future 20: 37-45, 1995.
308. MONFERINI, E., GIRALDO, E., AND LADINSKY, H.: Characterization of the muscarinic receptor subtypes in the rat urinary bladder. Eur. J. Pharmacol. 147: 453-458, 1988.
309. MORISSET, J., GEOFFRION, L., LAROSE, L., LANOE, J., AND POIRIER, G. G.: Distribution of muscarinic receptors in the digestive tract organs. Pharmacology 22: 189-195, 1981.
310. MORITA, T., ANDO, M., KIHARA, K., AND OSHIMA, H.: Function and distribution of autonomic receptors in canine ureteral smooth muscle. Neurourol. Urodyn. 13: 315-321, 1994.
311. MORIZAKI, N., MORIZAKI, J., HAYASHI, R. H., AND GARFIELD, R. E.: A functional and structural study of the innervation of the human uterus. Am. J. Obs. Gynecol. 160: 218-228, 1989.
312. MORLEY, J.: Parasympatholytics in asthma. Pulm. Pharmacol. 7: 159-168, 1994.
313. MORO, V., KACEM, K., SPRINGHETTI, V., SEYLAZ, J., AND LASBENNES, F.: Microvessels isolated from brain: localization of muscarinic sites by radioligand binding and immunofluorescent techniques. J. Cereb. Blood Flow Metab. 15: 1082-1092, 1995.
314. MOUMMI, C., MAGOUS, R., STROSBERG, D., AND BALI, J.-P.: Muscarinic receptors in isolated smooth muscle cells from gastric antrum. Biochem. Pharmacol. 37: 1363-1369, 1988.
315. NEDOMA, J., DOROFEEVA, N. A., TUCEK, S., SHELKOVNIKOV, S. A., AND DANILOV, A. F.: Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum. Naunyn Schmiedebergs Arch. Pharmacol. 329: 176-181, 1985.
316. NEWGREEN, D. T., ANDERSON, C. W. P., CARTER, A. J., AND NAYLOR, A. M.: Darifenacin-a novel bladder selective agent for the treatment of urge incontinence, Proceedings of the 25th Annual Meeting of the International Continence Society, 1995.
317. NEWGREEN, D. T., AND NAYLOR, A.: Comparison of the functional muscarinic receptor selectivity of darifenacin with tolterodine and oxybutyin (Abstract). Br. J. Pharmacol. 117: 107P, 1996a.
318. NEWGREEN, D. T. AND NAYLOR, A. M.: Characterisation of functional muscarinic receptors in human bladder. Br. J. Pharmacol. 119: 45P, 1996b.
319. NILVEBRANT, L., ANDERSSON, K.-E., AND MATHIASSON, A.: Characterization of the muscarinic cholinoceptors in the human detrusor. J. Urol. 184: 418-423, 1985.
320. NILVEBRANT, L., GLAS, G., JONSSON, A., AND SPARF, B.: The in vitro pharmacological profile of tolterodine - a new agent for the treatment of urinary urge incontinence (Abstract). Neurourol. Urodyn. 13: 433-435, 1994.
321. NILVEBRANT, L. AND SPARF, B.: Differences between binding affinities of some antimuscarinic drugs in the parotid gland and those in the urinary bladder and ileum. Acta Pharmacol. Toxicol. 53: 304-313, 1988.
322. NISHIZUKA, Y.: Studies and perspectives of protein kinase C. Science (Wash. DC) 233: 305-312, 1986.
323. 3 muscarinic receptors in human pulmonary artery. Br. J. Pharmacol. 119: 149-157, 1996.
324. NORONHA-BLOB, L., LOWE, V., PATTON, A., CANNING, B., COSTELLO, D., AND KINNIER, W. J.: Muscarinic receptors: relationships among phosphoinositide breakdown, adenylyl cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea-pig bladder. J. Pharmacol. Exp. Ther. 249: 843-851, 1989.
325. NUNN, P. A., GREENGRASS, P. M., NEWGREEN, D. T., NAYLOR, A. M., AND WALLIS, R. M.: The binding profile of the novel muscarinic receptor antagonist darifenacin against the five cloned human muscarinic receptors expressed in CHO cells. Br. J. Pharmacol. 117: 130P, 1996
326. OBI, T., KABEYAMA, A., AND NISHIO, A.: Characterization of muscarinic receptor subtype mediating contraction and relaxation in equine coronary artery in vitro. J. Vet. Pharmacol. Ther. 17: 226-231, 1995.
327. O'MALLEY, K. E., FARRELL, C. B., O'BOYLE, K. M., AND BAIRD, A. W.: Cholinergic activation of Cl- secretion in rat colonic epithelia. Eur. J. Pharmacol. 275: 83-89, 1995.
328. ORDWAY, G. A., ESBENSHADE, T. A., KOLTA, M. G., GERALD, M. C., AND WALLACE, L. J.: Effect of age on cholinergic muscarinic responsiveness and receptors in the rat urinary bladder. J. Urol. 136; 492-496, 1986.
329. ORIOWO, M. A.: Muscarinic receptor subtype in the rat anococcygeus muscle. J. Pharm. Pharmacol. 35: 469-470, 1983.
330. O' ROURKE, S. T. AND VANHOUTTE, P. M.: Subtype of muscarinic receptors on adrenergic nerves and vascular smooth muscle of the canine saphenous vein. J. Pharmacol. Exp. Ther. 241: 64-76, 1987.
331. O'ROURKE, S. T. AND VANHOUTTE, P. M: Adrenergic and cholinergic regulation of bronchial vascular tone. Am. Rev. Resp. Dis. 146: S11-S14, 1992.
332. OSINSKI, M. A. AND BASS, P.: Increased active stress generation of denervated rat intestinal smooth muscle: functional analysis of muscarinic receptor population. J. Pharmacol. Exp. Ther. 268: 1368-1373, 1994.
333. OYASU, H., YAMAMOTO, T., SATO, N., SAWADA, T., OZAKI, R., MUKAI, T., OZAKI, T., NISHII, T., SATO, H., FUJISAWA, H., TOZUKA, Z., KOIBUCHI, Y., HONBO, T., ESUMI, K., OHTSUKA, M., AND SHIMOMURA, M.: Urinary bladder selective action of the new antimuscarinic compound vamicamide. Arzneimittelforschung 4: 1242-1249, 1994.
334. OZKUTLU, U., ALICAN, I., KARAHAN, F., ONAT, F., YEGEN, B. C., ULUSOY, N. B., AND OKTAY, S.: Are m-cholinoceptors of guinea-pig gall bladder smooth muscle of m4 subtype? Pharmacology 46: 308-314, 1993.
335. PANG, I. H., MATSUMOTO, S., TAMM, E., AND DE SANTIS, L.: Characterization of muscarinic receptor involvement in human ciliary muscle cell function. J. Ocul. Pharmacol. 10: 125-136, 1994.
336. PAREKH, A. B. AND BRADING, A. F.: The sources of calcium for carbachol-induced contraction in the circular muscle of guinea-pig stomach. Br. J. Pharmacol. 104: 412-418, 1991.
337. PATEL, H. J., BARNES, P. J., TAKAHISHI, I. T., TADJIKARIMI, S., YACOUB, M. H., AND BELVIS, M. G.: Evidence for prejunctional muscarinic autoreceptors in human and guinea-pig trachea. Am. J. Crit. Care Med. 152: 872-878, 1995.
338. PATON, W. D. M. AND RANG, H. P.: The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors. Proc. R. Soc. Lond. B. Biol. Sect. 163: 1-44, 1965.
339. PEDDER, E. K., EVELEIG, P., POYNER, D., HULME, E. C., AND BIRDSALL, N. J. M.: Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes. Br. J. Pharmacol. 103: 1561-1567, 1991.
340. PENDRY, Y. D.: Neuronal control of airways smooth muscle. Pharmacol. Ther. 57: 171-202, 1993.
341. PENNEFATHER, J. N., GILLMAN, T. A., AND MITCHELSON, F.: Muscarinic receptors in rat uterus. Eur. J. Pharmacol. 262: 297-300, 1994.
342. PETERSEN, O. H. AND WAKUI, M.: Oscillating intracellular Ca2+ signals evoked by activation of receptors linked to inositol lipid hydrolysis: mechanism of generation. J. Membrane Biol. 118: 93-105, 1992.
343. 2-selective muscarinic receptor antagonist. Eur. J. Pharmacol. 86: 229-240, 1995.
344. PFAFFENDORF, M. AND VAN ZWIETEN, P. A.: Mediation by the same muscarinic receptor subtype of phasic and tonic contractile activities in the rat isolated portal vein. Br. J. Pharmacol. 108: 132-138, 1993.
345. 1-muscarinic receptors. Gen. Pharmacol. 23: 659-664, 1992.
346. POST, J. M. AND HUME, J. R.: Ionic basis for spontaneous depolarizations in isolated smooth muscle cells of canine colon. Am. J. Physiol. 263: C691-C699, 1992.
347. POST, M. J., TE BIESEBEEK, J. D., DOODS, H. N., WEMER, J., VAN ROOIJ, H. H., AND PORSIUS, A. J.: Functional characterization of the muscarinic receptor in rat lungs. Eur. J. Pharmacol. 202: P 67-92, 1991.
348. POYER, J. F., GABELT, B. T., AND KAUFMAN, P. L.: The effect of muscarinic agonists and selective receptor subtype antagonists on the contractile response of the isolated rhesus monkey ciliary muscle. Exp. Eye Res. 59: 729-736, 1994.
349. PRESTWICH, S. A. AND BOLTON, T. B.: G protein involvement in muscarinic receptor-stimulation of inositol phosphates in longitudinal smooth muscle from the small intestine of the guinea-pig. Br. J. Pharmacol. 114: 119-126, 1995.
350. PRIETO, D., BENEDITO, S., RIVERA, L., HERNANDEZ, M., AND GARCIA-SACRISTAN, A.: Autonomic innervation of the equine urinary bladder. Anat. Histol. Embryol. 19: 276-287, 1990.
351. PSOSKA, J. AND TUCEK, S.: Competition between positive and negative allosteric effectors on muscarinic receptors. Mol. Pharmacol. 48: 696-702, 1995.
352. PYNE, N. J., GRADY, M. W., SHEHNAZ, D., STEVENS, P. A., PYNE, S., AND ROGERS, I. W.: Muscarinic blockade of β-adrenoceptor-stimulated adenylyl cyclase: the role of stimulatory and inhibitory guanine-nucleotide binding regulatory proteins (Gs and Gi). Br. J. Pharmacol. 107: 881-887, 1992.
353. PYNE, N. J., GRADY, M., AND STEVENS, P.: Phorbol ester (PMA) challenge of tracheal smooth muscle cells and its effect on adenylyl cyclase, Gs and intracellular cyclic AMP (Abstract). Br. J. Pharmacol. 108: 74P, 1993.
354. PYNE, N. J. AND PYNE, S.: G-proteins in airways smooth muscle. In Airway Smooth Muscle: Biochemical Control of Contraction and Relaxation, ed. by D. Raeburn and M. A. Giembycz, pp.187-213, Birkhauser-Verlag, Basel. Switzerland, 1994.
355. RABE, K. F., DENT, G., AND MAGNUSSEN, H.: Hydrogen peroxide contracts human airways in vitro: role of epithelium. Am. J. Physiol. 269: L332-L338, 1995.
356. RAEBURN, D., HAY, D. W. P., FARMER, S. G., AND FEDAN, J. S.: Epithelium removal increases the reactivity of human isolated tracheal muscle to methacholine and reduces the effect of verapamil. Eur. J. Pharmacol. 123: 451-453, 1986.
357. RAMNARINE, S. I., HADDAD, E.-B., KHAWAJA, A. M., MAK, J. C. W., AND ROGERS, D. F.: On muscarinic control of neurogenic mucus secretion in ferret trachea. J. Physiol. 494: 577-586, 1996.
358. 2 receptors and β-adrenoceptor subtypes in guinea-pig isolated ileum. Br. J. Pharmacol. 114: 49-56, 1995.
359. REN, L. M., NAKANE, T., AND CHIBA, S.: Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated perfused simian coronary arteries. J. Cardiovasc. Pharmacol. 22: 841-846, 1993.
360. RESNICK, N. M.: Urinary incontinence. Lancet 346: 94-99, 1995.
361. RESTORICK, J. M. AND MUNDY, A. R.: The density of cholinergic and α- and β-adrenergic receptors in the normal and hyper-reflexic human detrusor. Br. J. Urol. 63: 32-35, 1989.
362. RICHARDS, M. H.: Pharmacology and second messenger interactions of cloned muscarinic receptors. Biochem. Pharmacol. 42: 1645-1653, 1991.
363. RICHARDS, M. H. AND VAN GIERSBERGEN, P. L. M.: Human muscarinic receptors expressed in A9L and CHP cells: activation by full and partial agonists. Br. J. Pharmacol. 114: 1241-1249, 1995.
364. RICHARDSON, J. B.: Nerve supply to the lung. Am. Rev. Respir. Dis. 119: 785-802, 1979.
365. RIEMER, R. K., GOLDFIN, A., AND ROBERTS, J. M.: Estrogen increases adrenergic but not cholinergic mediated production of inositol phosphates production in rabbit uterus. Mol. Pharmacol. 32: 663-668, 1988.
366. RIKER, W. F. AND WESCOE, W. C.: The pharmacology of flaxidil with observations on certain analogs. Ann. N.Y. Acad. Sci. 54: 373-392, 1951.
367. RINGDAHL, B.: Structural requirements for muacarinic receptor occupation and receptor activation by oxotremorine analogs in the guinea-pig ileum. J. Pharmacol. Exp. Ther. 232: 67-73, 1985.
368. RINGDAHL, B. AND JENDEN, D. J.: Affinity, efficacy and stereoselectivity of oxotremorine analogues for muscarinic receptors in the isolated guinea-pig ileum. Mol. Pharmacol. 23: 17-25, 1983.
369. RIVERA, L., HERNANDEZ, M., BENEDITO, S., PRIETO, D., AND GARCIA-SACRISTAN, A.: Mediation of contraction by cholinergic receptors in the ureterovesical junction. J. Auton. Pharmacol. 12: 175-181, 1992.
370. ROETS, E., BURVENICH, C., AND ROBERTS, M.: Muscarinic receptor subtypes, β-adrenoceptors and cAMP production in the tracheal smooth muscle of convential and double-muscled calves. Vet. Res. Commun. 16: 465-467, 1992.
371. 3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm. Pharmacol. 3: 47-51, 1989.
372. 2-like receptors. Eur. J. Pharmacol. 250: 267-279, 1993a.
373. 2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function. Eur. J. Pharmacol. 153: 73-82, 1988.
374. ROFFEL, A. F., HAMSTRA, J. J., ELZINGA, C. R. S., AND ZAAGSMA, J.: Selectivity profile of some recent muscarinic antagonists in bovine and guinea-pig trachea and heart. Arch. Int. Pharmacodyn. Ther. 328: 82-98, 1994b.
375. ROFFEL, A. F., MEURS, H., ELZINGA, C. R. S., AND ZAAGSMA, J.: Characterization of the muscarinic receptor subtype involved in phosphoinositide metabolism in bovine tracheal smooth muscle. Br. J. Pharmacol. 99: 293-296, 1990.
376. 2 receptors do not participate in the functional antagonism between methacholine and isoprenaline in guinea-pig tracheal smooth muscle. Eur. J. Pharmacol. 249: 235-238, 1993b.
377. 2 receptors in functional antagonism in bovine trachea. Br. J. Pharmacol. 115: 665-671, 1995.
378. ROFFEL, A. F., MEURS, H., AND ZAAGSMA, J.: Muscarinic acetylcholine receptors and control of smooth muscle tone. Trends Pharmacol. Sci. 15: 407-408, 1994a.
379. ROSENTHAL, A. J. AND MCMURTRY, C. T.: Urinary incontinence in the elderly. Postgrad. Med. 97: 109-121, 1996.
380. RUGGIERI, M. R. AND LUTHIN, G. R.: Identification of muscarinic receptor subtypes in human and rabbit bladder (Abstract). FASEB J. 4: 4327, 1990.
381. RUGGIERI, M. R., BODE, D. C., LEVIN, M. R., AND WEIN, A. J., Muscarinic receptor subtypes in human and rabbit bladder. Neurourol. Urodyn. 6: 119-128, 1987.
382. RUGGIERI, M. R., COLTON, M. D., WANG, P., WANG, J., SMYTH, R. J., PONTARI, M. A., AND LUTHIN, G. R.: Human prostate muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 274: 976-982, 1995.
383. SAENZ DE TEJADA, I., BLANCO, R., GOLDSTEIN, I., AZADZOI, K., DE LAS MORENAS, A., KRANE R. J., AND COHEN, R. A.: Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue. Am. J. Physiol. 264: H459-H467, 1988.
384. SAHIN, I. AND ILHAN, M.: Cardioselective antimuscarinic action of a dopamine receptor agonist, N, N-dipropyl-2-aminotetralin (TL-68). Arch. Int. Pharmacodyn. Ther. 290: 185-192, 1987.
385. SANGER, G. J. AND BENNETT, A.: Secoverine hydrochloride is a muscarinic antagonist in human gastrointestinal muscle and myometrium. J. Pharm. Pharmacol. 33: 711-714, 1981.
386. SANDERS, K. M.: Ionic mechanisms of electrical rhythmicity in gastrointestinal smooth muscles. Ann. Rev. Physiol. 54: 439-453, 1992.
387. SANKARY, R. M., JONES, C. A., MADISON, J. M., AND BROWN, J. K.: Muscarinic Cholinergic inhibition of cyclic AMP accumulation in airway smooth muscle: role of a pertussis toxin-sensitive protein. Am. Rev. Respir. Dis. 138: 145-150, 1988.
388. SAWYER, P. J. T., MCRITCHIE, B., HERNER, P. A., SLOWE, S. J., AND WALLIS, R. M.: In vivo gut selectivity of the novel antagonist, darifenacin, in the conscious dog. Br. J. Pharmacol., 118: 144P, 1996.
389. SCHAEFER, O. P., ETHIER, M. F., AND MADISON, J. M.: Muscarinic regulation of cyclic AMP in bovine trachealis cells. Am. J. Respir. Cell Mol. Biol. 13: 217-226, 1995.
390. 2 receptors in regulating β-adrenergic responsiveness in maturing rabbit airway smooth muscle. Am. J. Physiol. 269: L783-L790, 1995.
391. SCHRAMM, C. M. AND GRUNSTEIN, M. M.: Assessment of signal transduction mechanisms regulating airway smooth muscle contractility. Am. J. Physiol. 262: L119-L139, 1992.
392. SCHUDT, C., BOER, R., ELTZE, M., RIEDEL, R., GRUNDLER, G., AND BIRDSALL, N. J.: The affinity, selectivity and biological activity of telenzepine enantiomers. Eur. J. Pharmacol. 165: 87-96, 1989.
393. SHIMA, S., KOMORIYAMA, K., HIRAI, M., AND KOUYAMA, H.: β-adrenergic stimulation of the adenosine 3′, 5′ monophosphate system regulated by cholinergic stimuli in the prostate. Biochem. Pharmacol. 32: 529-533, 1983.
394. SHIRAISHI, K. AND TAKAYANAGI, I.: Subtype of muscarinic receptors mediating relaxation and contraction in the rat iris dilator smooth muscle. Gen. Pharmacol. 24: 139-142, 1993.
395. SHUBA, M. F.: Smooth muscle of the ureter: the action of excitation and mechanisms of action of catecholamines and histamine. In Smooth Muscle: An Assessment of Current Knowledge, ed. by E. Bulbring, A. F. Brading, A. W. Jones, and T. Tomita, pp. 377-384, Arnold, London, UK, 1981.
396. SOMLYO, A. P. AND HIMPENS, B.: Cell activation and its regulation in smooth muscle. FASEB J. 3: 2266-2276, 1989.
397. SOMOGYI, G. T. AND DE GROAT, W. C.: Evidence for inhibitory nicotinic and facilitatory muscarinic receptors on cholinergic nerve terminals of the rat urinary bladder. J. Auton. Nerv. Syst. 37: 89-97, 1992.
398. 1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder. J. Physiol. 480: 81-89, 1995.
399. SPERO, L.: Atropine blockade of cholinergic drugs on rabbit stomach muscle. Can. J. Physiol. Pharmacol. 58: 873-876, 1978.
400. SPINA, D.: Epithelium-dependent regulation of airways smooth muscle tone. In Airways Smooth Muscle: Development and Regulation of Contractility, ed. by D. Raeburn and M. A. Giembycz, pp. 259-290, Birkhauser Verlag, Basel, Switzerland, 1994.
401. 2-adrenoceptors. Br. J. Pharmacol., in press, 1996.
402. STEPHENSON, J. A., GIBSON, R. E., AND SUMMERS, RJ.: An autoradiographic study of muscarinic cholinoceptors in blood vessels: no localization to the vascular endothelium. Eur. J. Pharmacol. 153: 271-283, 1988.
403. SU, N. AND NARAYANAN, N.: Age related alteration in cholinergic but not α-adrenergic response of rat coronary artery vasculature. Cardiovasc. Res. 27: 284-290, 1993.
404. 3 antagonist in detrusor instability (Abstract). Proceedings of the 25th meeting of the Continence Society 117, 1995.
405. 3 muscarinic receptors mediate an increase in both inositol trisphosphate production and cyclic AMP formation in dog iris sphincter smooth muscle. J. Ocul. Pharmacol. 10: 137-147, 1994.
406. TAIRA, N.: The autonomic pharmacology of the bladder. Ann. Rev. Pharmacol. 12: 197-208, 1972.
407. TAKAHASHI, T., BELVISI, M. G., PATEL, H., WARD, J. K., TADJKARIMI, S., YACOUB, M. H., AND BARNES, P. J.: Effect of Ba 679 BR, a novel long acting anticholinergic agent, on cholinergic neurotransmission in guinea-pig and human airways. Am. J. Respir. Crit. Care Med. 180: 1640-1645, 1994a.
408. 3 receptor in guinea-pig gall bladder. Am. J. Physiol. 267: G523-G528, 1994b.
409. TAKAHASHI, Y., ABOSELF, S. R., BENARD, F., STIEF, C. G., LUE, T. F., AND TANAGHO, E. A.: Effect of intracavernous simultaneous injection of acetylcholine and vasoactive intestinal polypeptide on canine penile erection. J. Urol. 148: 446-448, 1992.
410. TEN BERGE, R. E., ZAAGSMA, J., AND ROFFEL, A. F.: Muscarinic inhibitory autoreceptors in different generations of human airways. Am. J. Crit. Care Med. 184: 43-49, 1996.
411. TETSURO, T., SHIN-ICHI, B., TAKASAKI, K., OKUMURA, M., SATO, H., TERAOKA, H., KITAZAWA, T., AND OHGA, A.: Muscle layer and regional differences in autonomie innervation and responsiveness to transmitter agents in swine myometrium. J. Auton. Pharmacol. 14: 213-227, 1994.
412. 2 muscarinic receptor in smooth muscle of guinea-pig ileum. Mol. Pharmacol. 4: 102-110, 1993.
413. 2 muscarinic receptor in contractions of guinea-pig trachea, guinea-pig esophagus and rat fundus. Biochem. Pharmacol. 51: 779-788, 1996.
414. TIEN, X-Y., WAHAWISAN, R., WALLACE, L. J., AND GAGINELLA, T. S.: Intestinal epithelial cells and musculature contain different binding sites. Life Sci. 36: 1949-1955, 1985.
415. 3H]-acetylcholine in the rabbit urinary bladder. Eur. J. Pharmacol. 281: 1-8, 1995.
416. TOKUNAGA, T., NISHIMURA, R., AND AKAGI, M.: Muscarinic receptors in human gastric mucosa. Jpn. J. Surg. 14: 122-126, 1984.
417. 4 induced contraction in the guinea-pig trachea. Eur. J. Pharmacol. 102: 549-553, 1984.
418. TORPHY, T. J.: β-adrenoceptors, cAMP and airway smooth muscle relaxation: challenges to the dogma. Trends Pharmacol. Sci. 15: 370-374, 1994.
419. TOSELLI, P., MORELAND, R., AND TRAISH, A. M.: Detection of m2 muscarinic acetylcholine receptor mRNA in human corpus cavernosum by in situ hybridization. Life Sci. 55: 621-627, 1994.
420. TRACEY, W. R., AND PEACH, M. J.: Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells. Circ. Res. 70: 234-240, 1992.
421. TRAISH, A. M., CARSON, M. P., KIM, N., GOLDSTEIN, I., AND SAENZ DE TEJADA, I.: Characterization of muscarinic acetylcholine receptors in human penile corpus cavernosum: studies on whole tissue and cultured endothelium. J. Urol. 144: 1036-1040, 1990.
422. TRAISH, A. M., KIM, N., CARSON, M. P., AND SAENZ DE TEJADA, I.: Characterization of muscarinic acetylcholine receptors in cultured bovine endothelial cells. J. Recept. Res. 14: 163-166, 1994.
423. TRAISH, A. M., SUE PALMER, M., GOLDSTEIN, I., AND MOSELAND, R. B.: Expression of functional muscarinic acetylcholine receptors subtypes in human corpus cavernosum and in cultured smooth muscle cells. Receptor 5: 159-176, 1996.
424. TRAURIG, H. H. AND PAPKA, R. E.: Autonomic efferent and visceral sensory innervation of the female reproductive system: special reference to the functional roles of the nerves in reproductive organs. In Nervous control of the Urogenital System, ed. by C. A. Maggi, pp.103-141, Harwood Academic Publishers, USA, 1993.
425. TUCEK, S. AND PROSKA, J.: Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16: 205-212, 1995.
426. 1-selective antagonist, telenzepine, had no bronchodilatory effects in COPD patients. Eur. Respir. J. 6: 328-331, 1993.
427. VAN AMSTERDAM, R. G. M., MEURS, H., BROUWER, F., POSTEMA, J. B., TIMMERMANS, A., AND ZAAGSMA, J.: Role of phosphoinositide metabolism in functional antagonism of airway smooth muscle contraction by β-adrenoceptor agonists. Eur. J. Pharmacol. 172: 175-183, 1989.
428. VAN CHARLDORP, K. J., AND VAN ZWIETEN, P. A.: Comparison of the muscarinic receptors in the coronary artery, cerebral artery and atrium of the pig. Naunyn Schmiedebergs Arch. Pharmacol. 339: 403-408, 1989.
429. VANHOUTTE, P. M., HUMPHREY, P. P. A., AND SPEDDING, M.: X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. Pharmacol. Rev. 48: 1-2, 1996.
430. VAN KOPPEN, C. J., RODRIGUES DE MIRANDA, J. F., BELD, A. J., HERMANUSSEN, M. W., LAMMERS, J-W. J., AND VAN GINNEKEN, C. A. M.: Characterization of the muscarinic receptor in human tracheal smooth muscle. Naunyn Schmiedebergs Arch. Pharmacol. 331: 247-252, 1985.
431. VAROL, F. G., HADJICONSTANTINOU, M., ZUSPAN, F. P., AND NEFF, N. H.: Pharmacological characterization of the muscarinic receptors mediating phosphoinositide hydrolysis in rat myometrium. J. Pharmacol. Exp. Ther. 249: 11-15, 1989a.
432. VAROL, F. G., HADUICCONSTANTINO, M., ZUPPAN, F. P., AND NEFF, N. H.: Gestational alterations in phospholipase C coupled muscarinic responses. Life Sci. 45: 1739-1743, 1989b.
433. VOCKERT, E. K., EGERER, H. P., TACKE, R., LAMBRECHT, G., AND MUTSCHLER, E.: Functional characterization of muscarnic receptors in rabbit peripheral lung. Life Sci. 52: 551 (Abstract), 1993.
434. VON SCHRENCK, T., MACKENSEN, B., MENDE, U., SCHMITZ, W., SIEVERS, J., MIRAU, S., RAEDLER, A., AND GRETEN, H.: Signal transduction pathways of the muscarinic receptors mediating gall bladder contraction. Naunyn Schmiedebergs Arch. Pharmacol. 349: 346-354, 1994.
435. VON SCHRENCK, T., SIEVERS, J., MIRAU, S., RAEDLER, A., AND GRETEN, H.: Characterization of muscarinic receptors on guinea-pig gallbladder smooth muscle. Gastroenterology 105: 1341-1349, 1993.
436. WAELBROECK, M., RENZETTI, A. -R., TASTENOY, M., BARLOW, R. B., AND CHRISTORPHE, J.: Inactivation of brain cortex muscarinic receptors by 4-diphenylacetoxy-1-(2-chloroethyl) piperidine mustard. Biochem. Pharmacol. 44: 285-290, 1992.
437. WAELBROECK, M., TASTENOY, M., CAMUS, J., CHRISTORPHE, J., STROHMANN, C., LINOH, H., ZILCH, H., TACKE, R., MUTSCHLER, E., AND LAMBRECHT, G.: Binding and functional properties of antimuscarinics of the hexocyclium/ sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes. Br. J. Pharmacol. 98: 197-205, 1989.
438. WALL, S. J., YASUDA, R. P., LI, M., AND WOLFE, B. B.: Development of an antiserum against m3 muscarnic receptors: distribution of m3 receptors in rat tissues and clonal cell lines. Mol. Pharmacol. 40: 783-789, 1991.
439. 3 receptor antagonists. Life Sci. 56: 861-868, 1995.
440. WALLIS, R. M., ALKER, D., BURGES, R. A., CROSS, P. E., NEWGREEN, D. T., AND QUINN, P.: Zamifenacin: a novel gut selective muscarinic receptor antagonist. Br. J. Pharmacol. 109: 36P, 1993.
441. 3 antagonist (Abstract). Pharmacol. Res. 31(suppl.): 54, 1995.
442. WANG, P., LUTHIN, G. R., AND RUGGIERI, M. R.: Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J. Pharmacol. Exp. Ther. 273: 959-966, 1996.
443. WANG, S. Z. AND EL-FAKAHANY, E. E.: Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists. J. Pharmacol. Exp. Ther. 266: 237-243, 1993.
444. WANG, S. Z., ZHU, S. Z., AND EL-FAKAHANY, E. E.: Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthase. J. Pharmacol. Exp. Ther. 268: 552-557, 1994.
445. 2 pathway in ileal smooth muscles. Biochem. Biophys. Res. Commun. 193: 483-489, 1993.
446. WATSON, N.: Autoregulation of cholinergic neurotransmission in airway nerves. In Airway Smooth Muscle: Structure, Function, Innervation and Neurotransmission, ed. by D. Raeburn and M. A. Giembycz, pp. 261-278, Birkhauser, Basel, Switzerland, 1994.
447. 3 receptor stimulation and antagonism on responses to isoprenaline of guinea-pig trachea in vitro. Br. J. Pharmacol. 112: 179-187, 1994a.
448. 3 receptors mediate contractions in rabbit endothelium-denuded aorta in vitro. J. Auton. Pharmacol. 14: 283-293, 1994b.
449. WATSON, N., MAGNUSSEN, H., AND RABE, K. F.: Pharmacological characterization of the muscarinic receptor subtype mediating contraction of human peripheral airways. J. Pharmacol. Exp. Ther. 274: 1293-1297, 1995a.
450. WATSON, N., MAGNUSSEN, H., AND RABE, K. F.: Antagonism of β-adrenoceptor-mediated relaxations of human bronchial smooth muscle by carbachol. Eur. J. Pharmacol. 275: 307-310, 1995b.
451. 3 receptors in guinea-pig trachea: effects of receptor alkylation. Eur. J. Pharmacol. 278: 195-201, 1995c.
452. WATSON, N., REDDY, H., AND EGLEN, R. M.: Characterization of muscarinic receptor and β-adrenoceptor interactions in guinea-pig oesophageal muscularis mucosae. Eur. J. Pharmacol. 294: 779-785, 1995d.
453. WATSON, N., REDDY, H., AND EGLEN, R. M.: Pharmacological characterization of the muscarinic receptors mediating contraction of the canine saphenous vein. J. Auton. Pharmacol. 15, 437-441, 1995e.
454. WATSON, N., REDDY, H., STEFANICH, E., AND EGLEN, R. M.: Characterization of the interaction of zamifenacin at muscarinic receptors in vitro. Eur. J. Pharmacol. 286: 135-142, 1995f.
455. WEIGER, N., SCHAFFER, K., WEGNER, U., SCHUSDZIARRA, V., CLASSEN, M., AND SCHEPP, W.: Functional characterization of a muscarinic receptor stimulating gastrin release from rabbit antral G-cells in primary culture. Eur. J. Pharmacol. 264: 337-344, 1994.
456. WHITE, M. V.: Muscarinic receptors in human airways. J. Allerg. Clin. Immunol. 98: 1065-1068, 1995.
457. 2 receptors in cultured human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 9: 541-546, 1993.
458. WILLIAMS, P. D., COLBERT, W. E., SHETLER, T. J., AND TURK, J. A.: Comparative pharmacological profile of muscarinic agonists in the isolated ileum, the pithed rat and the mouse charcoal meal transit test. Gen. Pharmacol. 23: 177-183, 1992.
459. WILLS-KARP, M.: Age-related changes in pulmonary muscarinic receptor binding properties. Am. J. Physiol. 265: L103-L107, 1993.
460. WILLS-KARP, M.: Effects of ageing upon airways smooth muscle contractility. In Airway Smooth Muscle: Development and Regulation of Contractility, ed. by D. Raeburn and M. A. Giembycz, pp. 185-218, Birkhauser, Basel, Switzerland, 1994.
461. WILSON, P. S., KHIMENKO, P. L., BARNARD, J. W., MOORE, T. M., AND TAYLOR, A. E.: Muscarinic agonists and antagonists cause vasodilation in isolated rat lung. J. App. Physiol. 78: 1404-1411, 1995.
462. - secretion in hen trachea. Am. J. Physiol. 258: C982-C987, 1990.
463. WITT-ENDERBY, P. A., YAMAMURA, H. I., HALONEN, M., LAI, J., PALMER, J. D., AND BLOOM, J. W.: Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment. Mol. Pharmacol. 47: 485-490, 1995.
464. WOLDEMUSSIE, E., FELDMANN, B. J., AND CHEN, J.: Characterization of muscarinic receptors in cultured human iris sphincter and ciliary smooth muscle cells. Exp. Eye Res. 56: 385-392, 1993.
465. YAMAGUCHI, O., SHISHIDO, K., TAMURA, K, OGAWA, T., AND FUJIMURA, T.: Evaluation of mRNA encoding muscarinic receptor subtypes in human detrusor muscle. Neurol. Urodyn. 13: 464-465, 1994.
466. YAMAGUCHI, O., SHISHIDO, K., TAMURA, K., OGAWA, T., FUJIMURA, T., AND OHTSKA, A.: Evaluation of mRNAs encoding muscarinic receptor subtypes in human detrusor muscle. J. Urol. 156: 1208-1213, 1996.
467. YAMAHARA, N. S., TANAKA, M., IMAIZUMI, Y., AND WATANABE, M.: Pertussis toxin-sensitive relaxation in the rat iris dilator muscle. Br. J. Pharmacol. 114: 777-784, 1995.
468. YAMAMOTO, T., MATSUO, M., YAMAZAKI, S., UESHIMA, K., SAWADA, T., FURUICHI, A., OZAKI, R., NISHI, M., MIURA, S., KASUNOKI, T., SATO, N., KOIBUCHI, Y., ESUMO, K., AND OHTSUKA, M.: Antimuscarinic properties of vamicamide, a novel compound for the treatment of pollakicuria. Drug Dev. Res. 34: 9-18, 1995.
469. 3H] quinuclidinyl benzilate. Mol. Pharmacol. 10: 861-867, 1974.
470. YANG, C. M.: Characterization of muscarinic receptors in dog tracheal smooth muscle cells. J. Auton. Pharmacol. 11: 51-61, 1991.
471. YANG, C. M., PARLEY, J. M., AND DWYER, T. M.: Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle. J. Auton. Pharmacol. 6: 15-24, 1986.
472. YASUDA, R. P., CIESLA, W., FLORES, L. R., WALL, S. J., LI, M., SATKUS, S. A., WEISSTEIN, J. S., SPAGNOLA, B. V., AND WOLFE, B. B.: Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 in rat bain. Mol. Pharmacol. 43: 149-157, 1993.
473. 3 muscarinic cholinoceptor subtype in rat prostate and its down regulation by aging. Jpn. J. Pharmacol. 61: 319-324, 1993.
474. YAZAWA, H., SAITA, Y., IIDA, E., HONMA, Y., MORITA, T., AND HONDA, K.: Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate. J. Urol. 162: 2173-2177, 1994.
475. YOKOYAMA, O., NAGANO, K., KAWAGUCHI, K., AND HISAZUMI, H.: The response of the detrusor muscle to acetylcholine in patients with infravesical obstruction. Urol. Res. 19: 117-121, 1991.
476. YOSHIMURA, M. AND COOPER, D. M.: Type-specific stimulation of adenylyl cyclase by protein kinase C. J. Biol. Chem. 268: 4604-4607, 1993.
477. YU, M., ROBINSON, N. E., WANG, Z., AND DERKSEN, F. J.: Muscarinic receptor subtypes in equine tracheal smooth muscle. Vet. Res. Commun. 16: 301-310, 1992.
478. ZHANG, L.: Muscarinic receptors in the developing rat colon. Eur J. Pharmacol. 304: 211-219, 1996.
479. ZHANG, L. AND BUXTON, I. L. O.: Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways. Mol. Pharmacol. 40: 952-959, 1991.
480. ZHANG, L. AND BUXTON, I. L. O.: Protein kinase regulation of muscarinic receptor signalling in colonic smooth muscle. Br. J. Pharmacol. 108: 613-621, 1993.
481. ZHANG, L., HOROWITZ, B., AND BUXTON, I. L. O.: Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes. Mol. Pharmacol. 40: 943-951, 1991.
482. ZHOLOS, A. V. AND BOLTON, T. B.: G-protein control of voltage dependence as well as gating of muscarinic metabotropic channels in guinea-pig ileum. J. Physiol. 478: 195-202, 1994.
483. ZHOLOS, A. V. AND BOLTON, T. B.: Muscarinic receptors activating cationic channels in smooth muscle (Abstract). Life Sci. in press.
484. ZWAGEMAKERS, J. M. A., AND CLAASSEN, V.: Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part I. Antimuscarinic and spasmolytic effects. Arzneimittelforschung 30: 1517-1526, 1980.